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„Der Mensch aber lebt nur ein Leben, er hat keine Möglichkeit, die Richtigkeit der 
Hypothese in einem Versuch zu beweisen. Deshalb wird er nie erfahren, ob es richtig 
oder falsch war, seinem Gefühl gehorcht zu haben.“  
(Milan Kundera, 1984)1 
                                               
1 Milan Kundera (1984). Die unerträgliche Leichtigkeit des Seins. Fischer Taschenbuch Verlag, 
Frankfurt am Main, p. 36. 
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Abstract 
Background. Cancer is a potentially life-threatening disease with increasing survival rates 
attended by adverse effects on physical and psychological well-being. In routine oncology 
practice, psychological complaints are often neglected, and many patients who might 
benefit from psychosocial support do not receive these services. To understand patients’ 
psychosocial health care needs and towards evidence-based change in clinical practice, 
patients’ needs are approached from the differing perspectives of the patient and the 
oncologist. Methods. We conducted a prospective, observational single-centre study in 
the Oncology Outpatient Clinic at the University Hospital Basel (Switzerland). Using the 
Distress Thermometer (DT), patients were routinely screened for psychosocial distress 
before their first consultation. Oncologists (n=25) then discussed distress and support 
options with patients (n=333). After the consultation, the oncologist’s perception of the 
conversation and screening procedure was assessed by means of a questionnaire. The 
patient’s perception of the conversation, as well as their psychosocial distress, support 
needs, and uptake of psycho-oncological service, were captured in two semi-structured 
interviews and questionnaires over a period of four months and analyzed using a mixed-
methods approach. Results. The analysis revealed that more than half of all cancer patients 
experienced elevated levels of psychosocial distress (DT³5). Two-thirds of all cancer 
patients were clear about their intention (yes or no) to use the psycho-oncology service 
while one third remained ambivalent (maybe). Patient intention was determined by 
perceived distress, attitude to psychological support, and coping strategies, as well as by 
other social and professional support. After four months, 23% of all patients had attended 
the psycho-oncology service (65% with yes intention, 12% with maybe intention, 7% with 
no intention). Patients who perceived a recommendation from their oncologist or who 
were not sure if they had perceived a recommendation were more likely to attend the 
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psycho-oncology service than those who clearly did not perceive a recommendation from 
their oncologist, as were younger patients, highly educated patients, and patients with high 
distress scores. In almost all cases, oncologists used this distress screening to open the 
conversation about psychosocial issues in the first consultation. However, patients often 
failed to recall this conversation, and this failure was predicted by higher age, higher 
distress, and attaching less importance to talk with the oncologist about distress. 
Conclusion. Severity of distress is associated with patient need for psycho-oncological 
support but is not the only deciding factor. Many patients are ambivalent about psycho-
oncological support and rely on oncologists to recommend these services. Repeated 
distress screenings, detailed information about the psycho-oncology service during the 
cancer trajectory, and an explicit recommendation from the treating oncologist to attend 
psycho-oncological services may improve comprehensive cancer care and prevent adverse 
effects on long-term psychological well-being among vulnerable cancer patients. 
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1   Preface 
Medical instruments measure CRP, PSA, and body temperature; machines analyse 
BRCA1/2, HER-2, and ER; PET-CTs, X-Rays, and mammography scans capture images 
of body cells. After undergoing all these tests and procedures, as well as pain and 
uncertainty, oncologists tell their patients that they have cancer—a malignant tumour 
involving degenerated cells that proliferate uncontrollably. This news causes shock and 
speechlessness in almost all patients. Standard procedures are then explained, treatment 
plans are outlined, and the next steps are discussed. At that moment, the most important 
thing for many patients are the restoration of support, control, and hope in a potentially 
life-threatening situation. During the medical treatment, which may involve 
chemotherapy, surgery, radiotherapy, immunotherapy, and so on, clinicians attend to all 
kinds of physical side effects like pain, nausea, diarrhoea, mucositis, and dermatitis, which 
strongly affect patients’ psychological well-being. However, in many cases, there is less 
attention to psychological side effects like disappointment, anger, fear, grief, sadness, 
hopelessness, identity crisis, altered body perception, and sorrow about one’s family and 
about the future. Although ubiquitous in everyday life, these psychological complaints 
may not be voiced, as survival is the principal goal. Yet as survival rates among cancer 
patients increase, psychological aftereffects like vulnerability, existential angst, 
depression, and fear of recurrence may be disabling, persisting for years or decades unless 
heard and addressed. 
Today, short psychosocial distress screenings are implemented in routine clinical 
oncology practice to identify cancer patients with psychological side effects and to initiate 
referral to psycho-oncological services. However, many cancer patients with high levels 
of psychosocial distress who might benefit from psycho-oncological support do not attend 
these services. Factors other than psychosocial distress might influence psychosocial 
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health care needs of cancer patients (e.g. patient-, organization-, communication-related 
factors). To improve comprehensive cancer care for cancer patients in need of supportive 
care services, the aim of the present study was to listen to the psychosocial health care 
needs of cancer patients and to patients’ and oncologists’ perspectives by understanding 
a) patients’ intentions to use psycho-oncological support, b) predictors of psycho-
oncological service uptake, and c) patients’ and oncologists’ perceptions of the 
conversation about psychosocial issues and psycho-oncological support. 
In a cumulative approach, the thesis draws on three publications accepted by or 
submitted to peer-reviewed scientific journals. These are embedded in an introductory 
section illustrating the two perspectives and inform the subsequent discussion of key 
findings. The insights gained are of relevance to international research in psycho-oncology 
and to everyday practice in clinical oncology. Most importantly, the research will benefit 
cancer patients by helping to reduce their suffering through listening, learning, and 
reinforcing their voice. 
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2   Introduction 
2.0 Background 
2.0.1 Cancer as major health concern 
Cancer is a major health concern worldwide. Advances in early diagnostics and more 
effective treatments mean that an increasing number of people affected by cancer will 
survive (Mehnert & Hartung, 2015). There are currently more than 15.5 million cancer 
survivors in the USA (Miller et al., 2016); in Switzerland there will be 372,000 cancer 
survivors by the end of 2020 (as compared to 289,797 in 2010; Herrmann et al., 2013). In 
short, mortality rates among patients diagnosed with cancer are decreasing, with longer 
progression-free survival rates for patients with non-curable cancers (Herrmann et al., 
2013). However, this means that the long-term side effects of cancer treatments are also 
prolonged. For many, cancer becomes a chronic disease; for others, it remains a life-
threatening disease. As both situations are attended by adverse short- and long-term effects 
on physical and psychological well-being (Mehnert & Hartung, 2015), health care policies 
in many countries now prioritise comprehensive care for cancer patients (Institut of 
Medicine, 2008; National Comprehensive Cancer Network, 2014; Schweizerische 
Gesellschaft für Psychoonkologie, 2014).  
2.0.2 Barriers to comprehensive cancer care 
In 2008, an influential report from the Institute of Medicine concluded that although there 
was evidence of the effectiveness of psychosocial support, many cancer patients who 
might benefit from psychosocial care did not attend these services (Institut of Medicine, 
2008). In 2014, a nationwide study involving 21,151 cancer patients in the UK 
demonstrated that 73% of cancer patients with comorbid major depression were still not 
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receiving any treatment for their depression (Walker et al., 2014). Of the remainder, 24% 
were prescribed antidepressants, and only 5% were seeing a mental health professional 
(Walker et al., 2014). The reasons for this lack of adequate psychosocial support include 
failure to detect mental disorders in the oncology setting; failure to provide psychosocial 
services at all settings (e.g. inpatient and outpatient settings); a lack of information about 
available services; no mandatory communication skills trainings for physicians; restricted 
consultation time; and sparse financial resources. Additionally, as there is (still) a stigma 
attached to mental illness and psychological support, patients may refuse support. 
Psychosocial distress screening (e.g. the Distress Thermometer (DT), see 
Appendix B) was implemented in routine clinical practice to improve comprehensive 
cancer care. The goal was to enable clinicians to rapidly identify cancer patients with 
elevated psychosocial distress and to initiate referral to psychosocial services (Carlson, 
Waller, & Mitchell, 2012; Fann, Ell, & Sharpe, 2012; Holland, Watson, & Dunn, 2011; 
Jacobsen, Holland, & Steensma, 2012). Today, distress screening programmes are 
mandatory in many countries for institutional certification as a Comprehensive Cancer 
Centre, as specified in guidelines, and international standards for comprehensive care of 
cancer patients (Bultz et al., 2015; Donovan, Grassi, McGinty, & Jacobsen, 2014; Lazenby 
et al., 2015; National Comprehensive Cancer Network, 2014; Pirl et al., 2014; Zebrack et 
al., 2015). However, as observed by Jimmie Holland, one of the founders of the field of 
psycho-oncology, ‘it is clear that establishing guidelines alone is not sufficient to change 
care’ (p. 677; Holland et al., 2011). 
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2.0.3 Two perspectives: patient and oncologist 
To remove the barriers to accessing appropriate supportive care services for cancer 
patients in need of psycho-oncological support, and to achieve meaningful and sustained 
changes in clinical practice, three perspectives on evidence-based medicine must be 
considered: the patient’s perspective (i.e. patient values & expectations), the oncologist’s 
perspective (i.e. clinical expertise), and the empirical evidence perspective (i.e. best 
external evidence; Figure 1; Kent et al., 2015; Sackett, Rosenberg, Gray, Haynes, & 
Richardson, 1996). 
 
Figure 1. Evidence-based medicine (EBM) triad (adapted from Armstrong, 2003). 
 
To date, the narratives of oncologists and patients have been largely overruled by 
more rigorous scientific evidence (e.g. randomized controlled trials; Kiss, 2015; Meisel & 
Karlawish, 2011). However, empirical evidence is useless if it cannot be applied in 
everyday clinical practice, and for that reason, the perspective of patients and oncologists 
are crucial (Kiss, 2015). In the present study, the aim was to revisit these two perspectives 
in the context of the current empirical evidence. 
Patient 
Values & 
Expectations
Individual 
Clinical 
Expertise
EBM
Best External 
Evidence/ 
Guidelines
The Patient’s 
Perspective
The Oncologist’s 
Perspective
The Empirical Evidence 
Perspective
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2.1 The patient’s perspective 
2.1.1 Psychosocial distress in patients with cancer 
The diagnosis of cancer evokes a range of emotional reactions in patients and their 
relatives, such as fear, anger, and sadness. Reacting emotionally to a potentially life-
threatening situation is normal, and all cancer patients experience some level of 
psychological distress during their disease trajectory from first indicators through 
diagnosis, effects, and treatment and on to the palliative or survivorship phase. According 
to the NCCN Guidelines (National Comprehensive Cancer Network, 2014): 
Distress is a multifactorial unpleasant emotional experience of a psychological (cognitive, 
behavioral, emotional), social, and/or spiritual nature that may interfere with the ability 
to cope effectively with cancer, its physical symptoms and its treatment. Distress extends 
along a continuum, ranging from common normal feelings of vulnerability, sadness, and 
fears to problems that can be disabling, such as depression, anxiety, panic, social 
isolation, and existential and spiritual crisis. (p. DIS-2) 
One cancer patient in every two suffers from subsyndromal levels of psychosocial 
distress (Carlson et al., 2004; Carlson, Groff, Maciejewski, & Bultz, 2010; Mitchell et al., 
2011; Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Cancer patients 
with untreated high levels of psychosocial distress are at risk for comorbid mental 
disorders (Mehnert et al., 2014; Mitchell et al., 2011; Singer, Das-Munshi, & Brähler, 
2010). 
2.1.2 Prevalence of mental disorders in cancer patients 
Mehnert and colleagues reported a 4-week prevalence rate of 31.8% for any mental 
disorder in a large German population of cancer patients (Mehnert et al., 2014), which is 
high when compared to the rate for the general population (20%; Jacobi et al., 2004). The 
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most common comorbid mental disorders include anxiety disorders (11.5%), adjustment 
disorders (11.0%), and mood disorders (6.5%; Mehnert et al., 2014). Additionally, many 
cancer-specific emotional states such as fear of cancer recurrence, demoralization, and 
subsyndromal psychosocial distress are not recorded in prevalence studies (Herschbach, 
2015). Psychological symptoms in cancer patients often fluctuate, they are closely linked 
to physical state and medical findings, and can be difficult to diagnose because of 
overlapping psychological and somatic symptoms (e.g. insomnia, fatigue, low appetite; 
Mitchell, Lord, & Symonds, 2012). Left untreated, psychiatric comorbidity can have 
significant adverse consequences for cancer treatment and survival, as these patients are 
at risk for non-adherence to cancer treatment (Kennard et al., 2004), reduced quality of 
life (Skarstein, Aass, Fossa, Skovlund, & Dahl, 2000), increased suicide risk (Kissane, 
2014), and a four times higher rate of requests for euthanasia (Van Der Lee et al., 2005). 
2.1.3 Evidence for psycho-oncological intervention 
Evidence from studies and meta-analyses confirms that psycho-oncological interventions 
such as individual or group psychotherapy, psychoeducation, and relaxation training 
significantly enhance quality of life, with a small-to-medium effect in reducing 
psychosocial distress, anxiety, and depression, and a medium-to-large effect when 
considering only those studies that preselected for highly distressed cancer patients (Faller 
et al., 2013; Gorin et al., 2012; Herschbach, 2015; Jacobsen et al., 2012; Kangas, Bovbjerg, 
& Montgomery, 2008). However, there is also evidence that psychological support is not 
beneficial for all cancer patients (Zhu et al., 2015), that many distressed cancer patients 
do not attend psycho-oncological support (Brebach, Sharpe, Costa, Rhodes, & Butow, 
2016), and that 37–54% of cancer patients report unmet supportive care needs (Beesley, 
Janda, et al., 2016; Faller, Koch, et al., 2016; Mehnert & Koch, 2008; Sanson-Fisher et 
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al., 2000). On that basis, there is a need for more studies of specific psycho-oncological 
interventions for different groups of cancer patients (e.g. young vs. old; women vs. men). 
2.1.4 Supportive care needs of patients with cancer 
Although some studies have shown that prevalence of high distress (normative need) and 
desire for support (felt need) are statistically correlated (Admiraal, van Nuenen, 
Burgerhof, Reyners, & Hoekstra-Weebers, 2016; van Scheppingen et al., 2011), other 
studies show no such correlation (Merckaert et al., 2010; Söllner, Maislinger, König, 
Devries, & Lukas, 2004). In fact, among cancer patients with high levels of psychosocial 
distress, 42–75% fail to report a need for psycho-oncological support (Baker-Glenn, Park, 
Granger, Symonds, & Mitchell, 2011; Carlson et al., 2004; Clover, Mitchell, Britton, & 
Carter, 2014; Shimizu et al., 2010; Söllner, Maislinger, König, Devries, & Lukas, 2004; 
van Scheppingen et al., 2011) while 10–44% of patients with low levels of psychosocial 
distress report a need for support (Bonacchi et al., 2010; Faller, Weis, et al., 2016; Söllner 
et al., 2004; van Scheppingen et al., 2011).  
Factors that predict need for supportive care include younger age, female sex, 
higher education, advanced cancer, shorter time since diagnosis, and greater symptom 
burden (Faller, Weis, et al., 2016; Fiszer, Dolbeault, Sultan, & Brédart, 2014). However, 
referring patients with a high level of distress to supportive care services has proved very 
difficult. Salmon and colleagues (Salmon, Clark, McGrath, & Fisher, 2015) explain this 
discrepancy from a health care perspective, concluding that need for supportive care 
entails three aspects: an expert-defined normative need for support (e.g. an elevated 
distress score on a screening tool) and a patient’s felt need (i.e. a wish or desire) for 
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support, which may become an expressed need for support (i.e. clear statement of intent 
to use a service) provided there is a known and available support service (see Figure 2).  
 
 
Figure 2. Need for psychological support from a health care perspective (adapted from 
ideas of Bradshaw et al., 2013, Salmon et al., 2015, and Sartorius, 2012). 
 
Patient need is an important indicator of whether professional help is wanted, but 
only a few qualitative studies have assessed patients’ reasons for declining psycho-
oncological help despite reporting high distress levels (Clover et al., 2015; Mosher et al., 
2014). Using eight pre-selected answers, Clover and colleagues found that highly 
distressed patients did not want psycho-oncological support principally because they 
preferred to manage themselves, they received help from another source, or they did not 
feel sufficiently distressed (Clover et al., 2015). 
Prevalence of 
high distress/ 
mental disorder
Clear intent/ 
demand of a 
service
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2.1.5 The gap between support need and uptake 
Not every felt need becomes an action (expressed need; Bradshaw, Cookson, Sainsbury, 
& Glendinning, 2013). One meta-analytic study found that uptake of psychological 
support in a clinical setting was 50%; once enrolled, however, 90% adhered to the support 
service (Brebach et al., 2016). A number of studies have examined barriers to uptake of 
psychosocial care, such as not knowing where to get help, a belief that the treatment does 
not work, concerns about what other people might think, and additional cost or effort 
(Dilworth, Higgins, Parker, Kelly, & Turner, 2014; Mosher et al., 2014; Neumann et al., 
2010). Most of these barriers could be addressed at informational and organizational level 
by offering adequate and low-threshold support services, informing patients about how a 
psychologist can help, and including psychosocial care in routine cancer care to reduce 
stigmatization (Azuero, Allen, Kvale, Azuero, & Parmelee, 2014). The fact that highly 
distressed patients who most likely benefit from psychological support do not engage with 
psychosocial support services invites formulation of more suitable offerings by listening 
to what cancer patients actually need. 
2.2 The oncologist’s perspective 
2.2.1 Let’s talk about psychosocial distress 
Psychosocial distress in cancer patients often goes unrecognized in routine oncology 
practice (Detmar, Aaronson, Wever, Muller, & Schornagel, 2000; Fallowfield, Ratcliffe, 
Jenkins, & Saul, 2001; Söllner et al., 2001). Although physicians have become 
increasingly aware of their responsibility to address cancer patients’ psychosocial issues, 
they still hesitate or rely on patients to initiate this discussion (Absolom et al., 2011; Taylor 
et al., 2011). One UK study showed that 59% of cancer patients and 75% of physicians 
said they would initiate a discussion about psychological issues; a further 30% of patients 
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said they would wait for the physician to address this issue. However, audio-recordings 
showed that psychological concerns were discussed in only 27% of all consultations and 
were mainly introduced by patients (85%; Taylor et al., 2011). 
Among oncologists, barriers to psychosocial communication with cancer patients 
include lack of consultation time, lack of support and feedback from colleagues and 
leaders, lack of resources to address upcoming problems, lack of methods and routines to 
evaluate distress, and skills deficits in communicating about psychosocial issues 
(Fagerlind, Kettis, Glimelius, & Ring, 2013). In general, physicians still seem to fear 
opening a Pandora’s box that cannot be closed, but the available evidence suggests 
otherwise; in fact, addressing psychological issues does not prolong consultation time 
(Eijzenga et al., 2014; Velikova et al., 2004), and most cancer patients appreciate the 
opportunity to discuss psychological concerns, which validates their needs (Jones, Regan, 
Ristevski, & Breen, 2011; Mackenzie, Carey, Sanson-Fisher, D’Este, & Yoong, 2015) 
without expecting oncologists to respond to their problem as psychologists might (Wright, 
Holcombe, & Salmon, 2004). 
2.2.2 Unsuccessful patient-oncologist communication 
Patient-oncologist communication is particularly challenging because of the intensity of 
emotions, the complexity of treatment options, and uncertainty about the future (Epstein 
& Street, 2007). Many studies have shown that patients’ and clinicians’ perceptions of 
what has been discussed consistently varies (Epstein, Prigerson, OReilly, & Maciejewski, 
2016; L. J. Fallowfield et al., 2017; Jenkins et al., 2011). While 58% of patients reported 
that fatigue limited their daily life more than pain while undergoing cancer treatment, only 
29% of oncologists shared this perception (Williams, Bohac, Hunter, & Cella, 2016). 
Gabrijel and colleagues (Gabrijel et al., 2008) found that 51% of lung cancer patients 
failed to recall information about the treatment goal (i.e. whether the primary intent of the 
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treatment was to cure the cancer) even though physicians reported having shared this 
information. Reasons for such mismatches of understanding can be identified on both 
sides; either physicians fail to fully or unambiguously disclose essential information, or 
patients fail to retain that information or are overly optimistic about their future.  
In addition, it is well known that patients remember only about seven items of 
information per consultation, provided that the physician uses a simple language, 
structures the conversation, delivers information in small units, and supplies the patient 
with additional written information (Finset, 2015; Kessels, 2003; Langewitz et al., 2015).  
2.2.3 Successful patient-physician communication 
In situations of existential threat, people look for a clinical relationship with someone they 
can trust, who is experienced, and who will guide them through the next steps (Beesley, 
Goodfellow, Holcombe, & Salmon, 2016). Physicians, on the other hand, seek to improve 
their patients’ situation by gathering as much information as possible and understanding 
the patient’s needs while performing a balancing act between telling the truth and 
sustaining hope (Bousquet et al., 2015; Langewitz, 2009).  
To achieve their respective goals, patients and physicians must be able to 
communicate successfully. Although this is a difficult task, effective communication has 
the potential to reduce cancer patients’ depression and anxiety (Fujimori et al., 2014; 
Schofield et al., 2003), increase adherence to cancer treatments (Grassi et al., 2017), 
improve satisfaction with care (Merckaert et al., 2015), and encourage patients to accept 
additional support (Jones et al., 2011). Oncologists whose training is psychosocially 
oriented see fewer barriers to communication (Fagerlind et al., 2013) and more frequently 
initiate communication about psychosocial distress (Book et al., 2013). It can be concluded 
that physicians can and should be educated in communication skills.  
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2.2.4 Communication skills training 
To improve communication during cancer care, communication skills training (CST) has 
been mandatory for oncologists in Switzerland since 2001 (Stiefel et al., 2011). Many 
studies have shown CST’s consistent effect on physicians’ communication skills and 
satisfaction (Barth & Lannen, 2011) but not on patient outcomes (Langewitz, 2017). One 
criticism is that CST focuses mainly on communication skills (e.g. maintaining eye 
contact, structuring information) rather than addressing the communication context as a 
whole (Stiefel & Bourquin, 2016), although we know that communication always happens 
in a context built by two (or more) persons who move in relation to each other like the 
swinging parts of a mobile (Langewitz, 2009).  
In several studies of surgeons and women with breast cancer, Salmon and 
colleagues found that patients’ trust in the clinical relationship was built on the clinician’s 
expertise and authority rather than through emotional engagement (Beesley et al., 2016; 
Salmon, Mendick, & Young, 2011; Wright et al., 2004; Young et al., 2013). In general, it 
is considered more helpful when, without disregarding the patient, physicians avoid 
displaying too much empathy. In the interest of their own health as well as the patient’s, 
oncologists need the professional skill to oscillate between proximity and distance, and 
between empathy and facts (Kiss, 2016). Oncologists bear a significant emotional burden 
and are at risk of exhaustion and burnout, which relate significantly to time spent with 
patients (Eelen et al., 2014). 
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3   Methods 
3.1 Research project 
3.1.1 Objectives 
The research project entitled "Understanding why cancer patients accept or turn down 
psycho-oncological support. A prospective observational study including patients’ and 
clinicians’ perspectives on communication about distress" emerged from a practical 
concern about clinical relevance. The objectives of the project were to assess barriers and 
predictors for uptake of psycho-oncological support in cancer patients and to determine 
how patients and oncologists perceive the conversation about psychosocial distress 
following screening. The study addressed the following research questions.  
1. From the patient’s perspective, what proportion of cancer patients intend, maybe 
intend, or do not intend to use the psycho-oncology service? Why do patients 
intend, maybe intend, or do not intend to use the psycho-oncology service? Which 
patient-related and patient-oncologist communication-related variables predict 
uptake of psycho-oncology services? 
2. From the oncologist’s perspective, how do oncologists make use of psychosocial 
distress screening procedures? Is there a difference between patients’ and 
oncologists’ recall of the conversation about psychosocial distress and psycho-
oncological support? 
We conducted a prospective, observational single-centre study in the Oncology Outpatient 
Clinic at the University Hospital Basel (Switzerland). The study was approved by the local 
ethics committee (Ethikkommission Nordwest- und Zentralschweiz, Ref.Nr. EK 220/13) 
and was funded by Krebsliga Schweiz. The methods used are summarised here; a detailed 
description is included in the study protocol (Zwahlen et al., 2017; see Appendix A).   
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3.1.2 Participants 
The study participants were cancer patients who presented for the first time at the Medical 
Oncology Outpatient Clinic at the University Hospital Basel between October 2013 and 
January 2016. To be included, patients had to be diagnosed with any solid tumour or 
hematologic malignancy, older than 18 years, fluent in German, physically and cognitively 
well enough to participate, and scheduled for at least one further consultation. Patients 
were pre-screened by their attending oncologist for eligibility and interest in joining the 
study. The participating clinicians were oncologists and residents from the hospital’s 
Medical Oncology Department. 
3.1.3 Standard distress screening procedure 
Based on a stepped–care model (National Comprehensive Cancer Network, 2014), all 
cancer patients were routinely screened for psychosocial distress at their first outpatient 
consultation. Before their first consultation with the oncologist patients completed the DT 
in the waiting room; the form included a description of the outpatient psycho-oncology 
service (see Appendix B). Where possible, the oncologist discussed the DT with the 
patient during the first consultation. Oncologists were advised to provide information 
about the psycho-oncology service to all patients and to recommend the service to those 
displaying a clinically relevant level of distress (DT≥5), or based on their clinical 
judgment or the patient’s wishes. The oncologists were trained in communication about 
psychosocial distress and referral to the psycho-oncology service. The psycho-oncological 
team was situated on the ward and integrated in the medical oncology team.  
3.1.4 Study procedure 
Following pre-screening by the attending oncologists, the study team informed eligible 
and interested patients about the study procedure. After signing the informed consent, 
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participants were interviewed by a member of the study team after the first consultation 
and again four months later. Participants received baseline and follow-up questionnaires 
by mail. Interviews were conducted by telephone or face-to-face, according to patient 
preference. Based on an interview manual, the interviews were semi-structured and 
conversational, and the interviewer made notes of the patient’s answers to open-ended 
questions. The oncologists completed a paper-pencil questionnaire after each consultation 
with a new patient. Figure 3 details the study procedure and measures. 
3.1.5 Measures 
Data were collected at three points in time (t1 screening, t2 baseline, t3 follow-up), using 
paper-and-pencil questionnaires and two semi-structured interviews (for details see Figure 
3 and Appendix A). Patients’ reasons for (non-)uptake of the psycho-oncology service 
were recorded in the interviews and qualitatively analysed. The primary outcome (at least 
one appointment at the outpatient psycho-oncology service) was retrieved from patients’ 
medical records four months after their entry to the study.  
3.1.6 Data analysis 
Quantitative data were analysed using SPSS version 22 (IBM, Armonk/NY, 2013). 
Descriptive methods were used to capture the frequency of categorical variables and the 
distribution of continuous variables. Contingency table analyses were used to assess 
agreement between patients’ and oncologists’ perceptions. Univariate and multivariate 
logistic regression analyses were used to assess the impact of predictor variables on uptake 
of the psycho-oncology service. Missing data were analysed, using multiple imputation 
where data were consistent with complete case analyses. Significance level was p ≤ .05. 
Answers to open-ended questions were edited using MAXQDA 12 (VERBI 
Software, Germany) software for qualitative analysis and analysed using content analysis 
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(Mayring, 2008). To ensure high quality content analysis, a team of trained researchers 
discussed the data. Inter-rater reliability was assessed using Cohen's kappa statistics (κ). 
 
 
Figure 3. Study procedure and study measures. 
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Abstract
Objective: Distress screening programs aim to ensure appropriate
psychooncological support for cancer patients, but many eligible patients do not use
these services. To improve distress management, we need to better understand
patients' supportive care needs. In this paper, we report the first key finding from a
longitudinal study that focused on patients' intentions to use psychooncological sup-
port and its association with distress and uptake of the psychooncology service.
Methods: We conducted a prospective, observational study in an Oncology
Outpatient Clinic and assessed distress, intention to use psychooncological support,
and uptake of the psychooncology service by using the Distress Thermometer, a
semistructured interview, and hospital records. We analyzed data with a mixed‐
methods approach.
Results: Of 333 patients (mean age 61 years; 55% male; 54% Distress Thermome-
ter ≥ 5), 25% intended to use the psychooncology service (yes), 33% were ambivalent
(maybe), and 42% reported no intention (no). Overall, 23% had attended the
psychooncology service 4 months later. Ambivalent patients reported higher distress
than patients with no intention (odds ratio = 1.18, 95% confidence interval [1.06‐
1.32]) but showed significantly lower uptake behavior than patients with an intention
(odds ratio = 14.04, 95% confidence interval [6.74‐29.24]). Qualitative analyses
revealed that ambivalent patients (maybe) emphasized fears and uncertainties, while
patients with clear intentions (yes/no) emphasized knowledge, attitudes, and coping
concepts.
Conclusions: We identified a vulnerable group of ambivalent patients with high distress
levels and low uptake behavior. To optimize distress screening programs, we suggest
addressing and discussing patients' supportive care needs in routine clinical practice.
KEYWORDS
cancer, Distress Thermometer, health‐care delivery, needs, oncology, psychological support,
psychooncology, reasons, screening, uptake
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1 | BACKGROUND
Cancer patients with untreated, high levels of psychosocial distress
are at risk for nonadherence to cancer treatment,1 reduced quality
of life,2 and comorbid mental disorders.3-6 Psychooncological inter-
ventions can effectively reduce distress,7 but many eligible patients
do not take advantage of support services.8,9 A third of all cancer
patients show clinically significant levels of psychosocial distress,3
but more than half of them do not want psychooncological support
(42‐75%),10-15 although many patients with less distress do want
support (10‐44%).11,15-17 Even patients who want and are offered
psychooncological support do not always use these services.18
Guidelines highlight the need to understand patients' supportive care
needs to remove barriers and facilitate access to psychosocial
services.8,18-20
Salmon et al20 referring to Jonathan Bradshaw21 recently brought
patients' supportive care needs into focus by acknowledging that
there is not only a normative need for support (defined by experts),
indicated by an elevated distress score on the Distress Thermometer
(DT) or other screening instruments, but also a felt need for support
like a wish or desire that can become an expressed need for support,
indicated, for example, by an expression of clear intent to use the
known and available psychooncology service. Previous studies exam-
ined why a cancer patient's distress level did not always conform to
their wish for support or adherence to services.10,17,18,22-25 Most stud-
ies have focused on patients with high distress levels, and few used
qualitative methods to understand patients' needs.26,27
We took an inductive, qualitative approach to understanding
patients' supportive care needs without dividing them a priori into
low‐ and high‐distress groups. Our longitudinal mixed‐methods design
supplemented qualitative analysis with quantitative assessment of dis-
tress and uptake of the outpatient psychooncology service in a longi-
tudinal mixed‐methods design. We formulated 3 research questions:
(1) What proportion of cancer patients intends, maybe intends, and
does not intend to use the psychooncology service? (2) How are
patients' intentions associated with distress and uptake of service?
(3) Why do patients intend, maybe intend, and not intend to use the
psychooncology service?
2 | METHODS
We report findings from a prospective, observational study in the
Oncology Outpatient Clinic of the University Hospital Basel (Switzer-
land). Our methods are briefly outlined below; we have described
them in more detail elsewhere.28
2.1 | Participants
Cancer outpatients who presented for the first time and used the out-
patient oncological care at the clinic were eligible when fulfilling the
inclusion criteria: ≥18 years, fluent in German, not being physically
or cognitively impaired in a way that impedes study participation,
and having at least 1 further consultation planned with an oncologist.
2.2 | Standard screening and referral procedure
Based on a stepped‐care model,19 patients were routinely screened
with the DT at their first outpatient consultation for psychosocial dis-
tress. A nurse asked patients to fill in the DT, which patients then
handed to the oncologist. All patients were given written information
about the outpatient psychooncology service. The service is available
for free and on short notice for all outpatients. Oncologists were
briefed to address psychosocial distress during the first consultation
and to recommend the service to patients, based on a clinically rele-
vant distress level (DT ≥ 5), their clinical judgment, or the patient's
wish.
2.3 | Study procedure
Oncologists screened cancer patients for interest to participate. The
study team informed interested patients about the study, obtained
informed consent, and interviewed participants an average of 15 days
after the first consultation. Semistructured interviews were conducted
in German and over the phone or face‐to‐face. Interviewers (TT and 7
Master's level students) relied on a manual. They were trained to use
comprehension questions, reflection, and summaries to clarify mutual
understanding; to take notes on participants' answers to open‐ended
questions during the interview, verbatim if possible; and to make
postscripts of the interviews immediately afterward.29 This study
complied with the Declaration of Helsinki. The local ethics committee
approved the study (Ethikkommission Nordwest‐und Zentralschweiz,
ref. no.: EK220/13).
2.4 | Measures
2.4.1 | Sociodemographic and clinical characteristics
Patients' sociodemographic data were recorded during the interview.
Clinical data were collected from patients' medical records.
2.4.2 | Psychosocial distress screening
We used the German version of the National Comprehensive Cancer
Network DT to assess self‐reported psychosocial distress on a visual
analogue scale from 0 to 10.30 The 1‐item screening tool shows good
reliability and validity and has a cutoff value of ≥5 for clinically signif-
icant levels of psychosocial distress (from 0 “no distress” to 10
“extreme distress”).30
2.4.3 | Intention and reasons for uptake of
psychooncological support
We asked the participants about their prospective intention during the
interview: “Do you intend to uptake the outpatient psycho‐oncologi-
cal support service in the next months?” The interviewer categorized
the participants' responses into 3 answers (yes/maybe/no), followed
by an open‐ended question: “What are the reasons why you do
[may/not] intend to use the outpatient psycho‐oncological support
service?”
TONDORF ET AL. 1657
  31 
 
2.4.4 | Uptake of the outpatient psychooncology
service
We defined uptake as having attended at least one appointment at the
outpatient psychooncology service within 4 months after study entry
and retrieved this information from hospital records.
2.5 | Data analyses
2.5.1 | Quantitative analyses
We conducted descriptive analyses for sociodemographic and clinical
data. To determine the association between a priori selected
sociodemographic variables, which are known to predict the use of
psychological support, distress, and intention, we performed a multi-
nomial logistic regression analysis. To determine the association
between intention and uptake, we performed a logistic regression
analysis. Results were presented as odds ratios with 95% confidence
intervals. The level of significance was set at P < .05. Analyses were
conducted by using SPSS Statistics version 22.0 (IBM, Armonk/NY,
2013).
2.5.2 | Qualitative analyses
We used content analysis to examine reasons for uptake of the
psychooncology service.31 This standardized, inductive approach ana-
lyzes qualitative data descriptively, adding a level of interpretation.32
To guarantee high‐quality content analyses, a team of trained
researchers (AG, DZ, and TT) discussed the patients' reasons in a mul-
tistep procedure. First, we read the answers of the patients several
times, divided the participants' answers into single reasons, and col-
lected ideas about categories. Second, we gathered categories in a
sample of 60 patients and refined them through an iterative process.
Third, we coded reasons of all patients into categories, discussed
inconsistence of assignment until consensus was reached, and
assessed interrater‐ reliability by using Cohen kappa statistics (κ).
Additionally, we identified main themes across categories. Analyses
were conducted by using MAXQDA software version 12.2.0 (VERBI
Software, Berlin, 2016).
3 | RESULTS
3.1 | Participant characteristics
Of 1240 outpatients who attended the clinic during 2013 to 2016 for
an outpatient consultation, 484 were ineligible because of no further
consultation, not being fluent in German, or being physically or cogni-
tively impaired. Of all patients who attended the clinic, 756 (61%)
were eligible for inclusion (Figure S1). In total, n = 333 patients com-
pleted the study (Table 1).
3.2 | Distress, intention, and uptake of the
psychooncology service
Of all participants, 53.5% showed high levels of psychosocial distress
(DT ≥ 5); distress was normally distributed among all participants.
Overall, 83 patients (25%) intended to use the psychooncology service
(yes), 111 patients (33%) were ambivalent (maybe), and 139 patients
(42%) did not intend to use the service (no). We found high distress
scores (DT ≥ 5) in 71% of patients with yes, 56% of patients with
maybe, and 42% of patients with no intention. After 4 months, 77
patients (23%) had used the service at least once (54 with yes inten-
tion [65% of all yes], 13 with maybe intention [12% of all maybe],
and 10 with no intention [7% of all no]). Figure 1 shows distributions
of uptake stratified according to levels of distress and intentions.
TABLE 1 Participants' sociodemographic and clinical characteristics
Participants (n = 333), Unless Otherwise Stated n %
Age, in Years
Mean (SD) 60.5 (14.0)
Range 19‐93
Sex
Female 151 45.3
Male 182 54.7
Education
Low (9th grade or less) 31 9.3
Middle (apprenticeship/high school) 186 55.9
High (diploma/university degree) 116 34.8
Living with a partner
Yes 233 70.0
No 100 30.0
Living with children
Yes 72 21.6
No 261 78.4
Distress thermometera
DT score 0‐4 132 46.5
DT score 5‐10 152 53.5
Time after initial cancer diagnosis, in weeks
Median (range) 4 (0‐264)
Cancer typeb
Breast cancer 67 20.1
Thoracic malignancies 59 17.7
Hematologic malignancies 51 15.3
Genitourinary cancer 28 8.4
Melanoma/skin cancer 27 8.1
Gastrointestinal (noncolorectal) cancer 22 6.6
Central nervous system tumors 16 4.8
Others 64 19.2
Treatment approach
Palliative 128 38.4
Curative 205 61.6
Current treatments (multiple treatments possible)
Systemic treatmentc 298 89.5
Radiotherapy 109 32.7
Surgery 34 10.2
No treatment/watch‐and‐wait/others 21 6.3
Abbreviations: SD, standard deviation; DT, Distress Thermometer.
an = 284, DT from n = 49 patients missing due to nondelivery of the DT by
clinical staff (n = 18), not being provided by patients (n = 22), and lost doc-
uments (n = 9).
bOne participant with 2 cancer types.
cSystemic treatment includes chemotherapy, immunotherapy, hormone
therapy, and targeted therapy.
1658 TONDORF ET AL.
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In a multinomial logistic regression, patients with yes intention
and patients with maybe intention were significantly more distressed
than patients with no intention (yes: mean = 5.8 [SD = 2.4]; maybe:
mean = 5.0 [SD = 2.6]; no: mean = 3.9 [SD = 2.7]). Age, sex, and edu-
cation did not differ between intention groups (Table 2A). In a logistic
regression analysis, patients with maybe and no intention showed sig-
nificantly lower uptake behavior than patients with yes intention
(Table 2B). This result did not materially change after adjustment for
sociodemographic variables (data not shown).
3.3 | Reasons for yes, maybe, or no intention
Patients gave a total of 734 reasons, averaging 2.2 reasons per patient
(min. 1, max. 6 reasons). Content analysis identified 32 categories of
Answer n (%) Answer n (%)
Low Distress
DT<5 n=132
Yes 20 (15.2) Yes 12 (60.0)
No 8 (40.0)
Maybe 39 (29.5) Yes 2 (5.1)No 37 (94.9)
No 73 (55.3) Yes 3 (4.1)No 70 (95.9)
High Distress
DT 5 n=152
Yes 50 (32.9) Yes 33 (66.0)No 17 (34.0)
Maybe 49 (32.2)
Yes 7 (14.3)
No 42 (85.7)
No 53 (34.9) Yes 6 (11.3)No 47 (88.7)
Distress UptakeIntention
T0; first consultation T1; 2 weeks after T0 T2; 16 weeks after T0 t
FIGURE 1 Description of patients' distress, intention, and uptake by distress level. Abbreviations: DT, Distress Thermometer; T0, screening; T1,
baseline; T2, follow‐up
TABLE 2 Associations among sociodemographic variables, distress, and intention as well as intention and uptake
(A) Multinomial Regression Analysis of Sociodemographic Variables and Distress on Intention
Intention Yes vs Noa Intention Maybe vs Noa Intention Yes vs Maybeb
B (SE) OR [95% CI] P Value B (SE) OR [95% CI] P Value B (SE) OR [95% CI] P Value
Distress (DT 0‐10) 0.28 (0.06) 1.32 [1.17‐1.49] <.001** 0.17 (0.06) 1.18 [1.06‐1.32] .003* 0.11 (0.06) 1.12 [0.99‐1.26] .078
Age −0.02 (0.01) 0.98 [0.96‐1.00] .107 −0.01 (0.01) 0.99 [0.97‐1.01] .406 −0.01 (0.01) 0.99 [0.97‐1.01] .410
Sex (0 = male, 1 = female) 0.19 (0.32) 1.21 [0.65‐2.24] .553 0.20 (0.29) 1.22 [0.69‐2.14] .497 −0.01 (0.33) 0.99 [0.52‐1.88] .980
Education (0 = low,
1 = high)
−0.14 (0.33) 0.87 [0.46‐1.66] .672 −0.11 (0.30) 0.90 [0.50‐1.62] .722 −0.03 (0.34) 0.97 [0.50‐1.88] .924
(B) Logistic regression analysis of intention on uptake
B (SE) OR [95% CI] P Value
Intention yes vs noa 3.18 (0.40) 24.02 [10.95‐52.71] <.001**
Intention maybe vs noa 0.54 (0.44) 1.71 [0.72‐4.07] .22
Intention yes vs maybeb 2.64 (0.37) 14.04 [6.74‐29.24] <.001**
Note. (A) Model χ2 (8) = 28.94, P < .001, n = 284, Nagelkerke R2 = 0.110. Education was dichotomized into “low/medium” (less than ninth grade/appren-
ticeship/high school) and “high” (diploma/university degree). (B) Model χ2 (2) = 100.66, P < .001, n = 333, Nagelkerke R2 = 0.395.
Abbreviations: B, Beta coefficient; SE, standard error; OR, odds ratio; CI, confidence interval; P value, significance level; DT, Distress Thermometer.
aReference group no intention.
bReference group maybe intention.
*P < .05.
**P < .001.
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patients' reasons and 4 main themes. Interrater reliability was strong
to moderate (κ = 0.70‐0.89).33 Table S1 contains a detailed description
of all categories and number of reasons per group.
Four main themes emerged across groups: attitude (ATT), coping
(COP), distress (DIS), and support (SUP). Attitude includes categories
that describe patients' opinions about psychooncological support.
Coping includes different strategies that patients say they used to han-
dle a situation. Distress consists of several categories that describe
either subjective distress or well‐being as a reason for uptake or
decline of support. Formal and informal support includes categories
that describe support needs of patients.
Patients with a yes intention wanted to consult psychooncologists
mainly because (1) they considered the psychooncologists to be expe-
rienced experts [ATT1], (2) they wanted support for self‐empower-
ment [COP1], and (3) they wanted to prepare for potential physical
or mental deterioration [DIS1]. Patients with no intention generally
(1) felt supported enough by family and friends [SUP2], (2) reported
mental and physical well‐being [DIS8], and (3) did not think psycholog-
ical support would be helpful [ATT9]. Ambivalent patients (maybe)
combined reasons for and against support, and they often described
a potential situation in which they would consider taking advantage
of support services (ie, if‐then thinking): (1) They wanted to use sup-
port if their physical or mental condition deteriorated [DIS1], (2) they
currently felt supported enough [SUP2], and (3) they felt physically
and emotionally well [DIS8]. Other reasons are listed in order of rank
in Table 3 and Table S1.
4 | DISCUSSION
To the best of our knowledge, this study is the first longitudinal,
observational study with prospective data along the distress screening
pathway assessing cancer patients' distress, intention, and uptake of
the psychooncology service focusing on patients' intentions by using
mixed methods.
Our study had 3 key findings. First, with a trichotomous assess-
ment of health‐care service needs (yes/maybe/no), we identified a
considerable number of ambivalent patients (33%), who had high
mean distress levels but were less likely to use services. Second,
we found an association between level of distress and patients'
intentions, but 67% of patients with a high distress level did not
intend to use support immediately. Third, qualitative analyses
revealed different motives of ambivalent patients and patients with
no or yes intention.
In line with previous research,13,15,22,34 we found that the level of
distress, but not age, sex, or education, was associated with the inten-
tion to use psychooncological support. However, about 35% of
patients with high distress levels did not intend, whereas 45% of
patients with low distress levels intended or maybe intended to use
support. The general assumption that high distress equates with a
need for support is based on a diagnostic model that recognizes
patients who are at risk for mental disorders.20,35 Predefining a cut‐
off value is a normative standard helpful for screening, but it must
be used carefully, because we screen for normative need but not, per
se, for patients' felt or expressed needs.20
Intention predicted uptake behavior, but 7% of patients with no
intention used the service, and 35% of patients with an intention
had not used the service after 4 months. Uptake behavior in ambiva-
lent patients was low (12%). Further studies need to explore the bar-
riers between intention and uptake.18
In the interview, patients with no intention emphasized social sup-
port and well‐being, which supported our quantitative result on low
distress values and aligned with previous research on highly distressed
patients who declined support.10 Patients' negative attitudes about
psychological support and their strong emphasis on self‐determination
and self‐management may indicate a patient concept avoiding help‐
seeking behavior, which is common in mental health‐care settings.10
Similarly, positive attitudinal aspects, knowledge, and coping con-
cepts were important for patients with an intention (yes). Attitudinal
aspects and knowledge are relevant to support‐seeking behav-
ior.24,36,37 Many of these patients had precise ideas of what they
wanted and would get when asking for psychooncological support,
which indicates that mental health literacy, knowledge, and patient
empowerment is an important aspect for service use.8,25
However, attitudes, experiences, or knowledge about support ser-
vices played a negligible role for most ambivalent patients (maybe).
Ambivalent patients stated reasons for and against support: Fears
and uncertainties were described as well as resources and well‐being.
Patients reported a lot of if‐then thinking and seemed to be open to
using the service at a later stage. In our clinical experience, a clear
treatment plan, medical appointments, and a focus on going through
the medical treatment psychologically stabilize patients. Dekker
et al38 argued that an increased distress level might indicate “adaptive
emotional responses, which facilitate coping with cancer” instead of a
maladaptive process. Further studies are needed.
Our study offers a novel, in‐depth qualitative analysis of patients'
supportive care needs, which revealed a threefold intention (yes/
maybe/no) and a divergent pattern of motives for declining
psychooncological support. Intention is relevant here because 67%
of highly distressed patients did not want to make immediate use of
the psychooncology service, but only 35% of these had no intention,
and 32% were ambivalent (maybe).
Our study has several strengths. First, to our knowledge, it is the
first study to monitor uptake behavior of patients after expressing
supportive care needs in a longitudinal study. Second, we qualitatively
analyzed patients' needs, a crucial extension of previous studies. Third,
we assessed a large sample of cancer patients in the early phase of
treatment with equal representation of men and women.
5 | STUDY LIMITATIONS
Our limitations are as follows: First, due to the large number of study
participants, we decided against audio records. Instead, we used the
qualitative method of taking notes during the interview and writing
reflective postscripts afterward.29 We countered possible interviewer
bias by relying on a detailed interviewer manual and closely supervis-
ing interviewers. Second, this was a single center study. Our sample
was representative for our clinic and other outpatient oncological set-
tings that use a stepped‐care model and integrate psychooncological
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care (eg, Comprehensive Cancer Centers). Third, oncologists did not
inform 13% of all eligible patients about the study, 28% of eligible
patients did not want more information about the study, and 12%
refused to participate after being informed. We adopted a recruitment
strategy where the consultant oncologist recruited the patients
because it offered several advantages. Oncologists are the first and
closest contact for outpatients, it is a naturalistic setting, and being
invited by a physician to participate in a psychooncological study
might reduce the stigma to accept the invitation. But there is also a
risk of bias if oncologists are more inclined to inform interested,
approachable patients about the study, or to invite patients with spare
time, or who they judged healthy enough to participate.
6 | CLINICAL IMPLICATIONS
It is essential to integrate patients' supportive care needs into the clin-
ical distress screening pathway. Patients with an ambivalent intention
to use support might go unrecognized in clinical practice because sup-
portive care needs are usually captured with a dichotomous response
format.13 We propose to assess the supportive care needs of patients
by using a trichotomous response format (yes/maybe/no) at the same
time as assessing psychosocial distress with the DT. The needs of
highly distressed patients who do not intend to use support services
(no) might be better met if approaches to these patients focused on
reducing stigmatization and enhancing self‐determination. In contrast,
it might be better to address the needs of highly distressed, ambiva-
lent patients (maybe) by taking an “if‐then” approach to discussions
about service uptake. Taking the right approach to meet the needs
of each patient group could optimize psychooncological health‐care
delivery. Supportive cancer care should also always include providing
detailed information to all patients about the work psychooncologists
do and the benefits of psychooncological treatments.
7 | CONCLUSION
Our study reveals patients' subjective needs linked to psychosocial
distress and uptake of a psychooncology service in cancer outpatients
by using mixed methods. We identified a vulnerable group of ambiva-
lent patients. To optimize distress screening programs, we suggest
that patients' supportive care needs should be addressed and
discussed in routine clinical practice.
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1 | BACKGROUND
Psychosocial distress and mental disorders are common among cancer
patients1,2 and should be addressed by psycho‐oncological interven-
tions to improve quality of life and reduce emotional distress.3,4 Rou-
tine distress screening tools implemented in oncological practice can
identify patients with elevated psychosocial distress so they can be
referred to psycho‐oncological services (POS),5 but 50% to 71% of
patients with clinically significant levels of psychosocial distress do
not use POS.6,7 Increasing adequate referral and usage of POS by
distressed patients and offering the support needed are a challenge
in psycho‐oncological care delivery.8,9
Although elevated psychosocial distress is positively associated
with POS uptake,10-12 distress level is not the only factor associated
with patient uptake of POS.13,14 Other factors also predict uptake,
including patient‐related characteristics like younger age,10,12,15 female
gender,10-12,15 higher education,15-17 and factors associated with the
oncological treatment.15,18,19 These patient‐related characteristics can-
not be modified. However, it is possible to design interventions that
target modifiable contextual aspects along the distress screening path-
way, including key aspects of patient‐oncologist communication after
distress screening, to better manage patient distress.20
So far, we know that patient‐oncologist communication during
the distress screening process might be positively linked to patients'
uptake behaviour and lead to more adequate referral to POS.8,21
Singer and colleagues22 found that a stepped care model in which
patients and oncologists discussed distress screening results
decreased referrals in patients without psychiatric comorbidities and
increased referrals in patients with psychiatric comorbidities compared
with the standard care model without a discussion. Some studies have
suggested that informing patients about the availability and benefits of
psychological support and providing them with practical information
about psycho‐oncological treatment may increase uptake of ser-
vices.9,10,17,23 There is also evidence that most patients would accept
a recommendation to use POS by their physician16 and that lack of a
recommendation by health care providers can be a barrier to POS
uptake.24 Improving patient‐oncologist communication after distress
screening is important because it may facilitate patients' understand-
ing, reduce uncertainty, help patients to make informed decisions
about their care, and increase satisfaction with care.23,25-27 As far as
we know, no study examined the association between various specific
communication variables in the patient‐oncologist communication
after distress screening and POS uptake in a large outpatient popula-
tion from the patient perspective.
We hypothesized that three patient‐oncologist communication
variables (talking, informing, and recommending) and previously identi-
fied patient‐related characteristics (younger age, female gender, higher
education level, palliative treatment intent, and higher psychosocial
distress) would be positively associated with POS uptake. In more
detail, patient‐oncologist communication variables were (a) talking,
during which the oncologist addressed the patients' individual psycho-
social distress; (b) informing, referring to detailed information about
the availability of POS provided by the treating oncologist; and (c)
recommending, reflecting the fact that the oncologist provided a rec-
ommendation to attend POS.
2 | METHODS
2.1 | Participants and setting
Data are based on a prospective, observational study conducted in the
Oncology Outpatient Clinic of the University Hospital Basel (Switzer-
land). In Switzerland, POS is available at most hospitals with oncolog-
ical centres, and costs are covered by basic health insurance. In these
institutions, POS is available on short notice by self‐referral or referral
of a physician. Psychotherapeutic support outside of the hospitals is
provided by psychotherapists in private practice and associated with
waiting lists, and costs that are not covered by basic insurance in every
case. Methods of the study have been described earlier.28 Cancer
outpatients who presented for the first time at the outpatient clinic
between October 2013 and January 2016 were eligible if they were
≥18 years old, fluent in German, not cognitively or physically impaired
in a way that impeded participation, and were scheduled for at least
one more outpatient consultation with an oncologist at the clinic.
2.2 | Standard screening procedure
Based on a stepped psycho‐oncological care model,29 all patients were
routinely screened for psychosocial distress with the distress ther-
mometer (DT) before their first outpatient consultation with the
oncologist and were given written information about the outpatient
POS. Screening for psychosocial distress is standard procedure for
new patients at the Oncology Outpatient Clinic and independent of
study participation. Oncologists were told to address the patient's psy-
chosocial distress level in the first consultation. They were advised to
recommend the POS to patients who reported high distress levels
(DT ≥ 5), as well as based on their clinical judgment, or the patient's
request. The actual referral to the POS was guided by patients' con-
sent. Oncologists participated in a 1‐hour training that taught them
how to communicate about psychosocial distress and how to follow
guidelines for referring patients to POS.
2.3 | Study procedure
Treating oncologists informed cancer patients about the study after
the first consultation to ascertain their interest in study participation.
Thereafter, the study team informed eligible and interested patients
about the study procedure in detail, obtained informed consent, and
interviewed participants after the first outpatient consultation (aver-
age time to interviews was 15 days, and ranged from 0 to 46 days).
Semistructured interviews on the phone or face to face were con-
ducted in German. Prompts and reflections were used to encourage
patients to talk and to elicit detail where necessary. Interviewers (TT,
AFN, and six further Master's level students) used an interviewer man-
ual and were closely supervised by a psycho‐oncologist and trained
researcher (DZ). The local ethics committee approved the study
(Ethikkommission Nordwest‐und Zentralschweiz, Ref. No.:
EK220/13), which complied with the Declaration of Helsinki.
2 FREY NASCIMENTO ET AL.
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2.4 | Measures
2.4.1 | Outcome variable
POS uptake was defined as having attended at least one appointment
at the Outpatient Psycho‐oncology Service at the University Hospital
Basel within 4 months after entering the study (yes/no). Data on POS
uptake were prospectively retrieved from hospital records.
2.4.2 | Predictor variables
Patients' sociodemographic and clinical data
Patients' sociodemographic data (age, gender, education) were
recorded during the interview; clinical data on patients' oncological
treatment (treatment intent) were collected from their medical
records.
Psychosocial distress
The German version of the National Comprehensive Cancer Network
distress thermometer was applied to screen patients for psychosocial
distress.30 The reliable and validated screening tool has one item
(“Please circle the number (0‐10) that best describes how much dis-
tress you have been experiencing in the past week including today”).
A score of ≥5 on the DT (from 0 “no distress” to 10 “extreme dis-
tress”) indicates clinically significant levels of psychosocial distress.
Psychosocial distress was also assessed in the interview with the
question, “How much distress have you been experiencing in the past
week including today on a scale from 0 “no distress” to 10 “extreme
distress?”
Patients' report of the communication with the oncologists
They were asked (a) talking: “Did the oncologist talk about your psy-
chosocial distress with you?” (answers: yes/no/do not know), (b)
informing: “Did the oncologist inform you about how the psycho‐
oncologist can provide support?” (answers: yes/no/do not know),
and (c) recommending: “Did the oncologist recommend that you
attend the psycho‐oncology service?” (answers: yes/no/do not
know).
2.5 | Data analyses
We descriptively analysed sociodemographic, clinical, and
communication‐related variables. Education was dichotomized into
“academic” (based on a university degree) and “nonacademic” (based
on high school, apprenticeship, or no education). Patients whose DT
scores were missing (due to n = 18 nondelivery by clinical staff;
n = 22 not provided by patients; n = 9 lost documents) were assessed
for distress during the interview, and DT values were replaced by
interview distress values in the analysis. To estimate predictors of
POS uptake, we used uptake as outcome variable (no uptake as refer-
ence group) in a multivariate logistic regression analysis. Patient‐
related variables known to predict POS uptake (including age, gender,
education, oncological treatment intent, and psychosocial distress)
were selected a priori. We also entered the three communication var-
iables (talking, informing, and recommending) with two dummy variables
each (yes vs no; do not know vs no) and used no as reference category.
We then tested the interaction of perceived recommendations with
distress. Additionally, to measure the effect of the communication var-
iables only, we calculated a multivariate logistic regression analysis
using all communication variables as predictors of POS uptake. We
present results as odds ratios (OR) with 95% confidence intervals
(95% CI). To evaluate the goodness of fit and predictive accuracy of
the model, we calculated Nagelkerke's R2 and the C‐statistic. We used
“R” (R Foundation for Statistical Computing, Vienna/Austria, 2008) to
analyse the data.
3 | RESULTS
3.1 | Participant and oncologist characteristics
Of 1240 patients who attended the clinic for an outpatient consulta-
tion during the study period, 756 (61%) were eligible for inclusion
(Figure S1, study flow). Of 1240 outpatients who attended the clinic
during 2013 to 2016 for a consultation, 484 patients were ineligible
because of no further consultation (n = 195), not being fluent in Ger-
man (n = 164), or being physically or cognitively impaired (n = 125).
Table 1 shows sociodemographic and clinical characteristics of 333
patients who completed the study (44% of eligible patients; 44% on
the phone, 56% face to face). Mean age was 61, 55% were men, mean
distress score was 4.7 (SD = 2.7), and 54% showed high levels of psy-
chosocial distress (DT ≥ 5). After 4 months, 77 patients (23%) had
used the POS. Twenty‐five oncologists participated in the study.
Mean age was 36 (range 28‐58 years), 13 were men, and professional
seniority ranged from 0 to 30 years. They were 9 senior oncologists
(professional seniority ≥6 years), 6 oncologists in training (professional
seniority ≤4 years), and 10 resident oncologists (professional seniority
≤2 years).
3.2 | Patients' report of the patient‐oncologist
communication
More than half of the patients (54%) recalled talking with the oncol-
ogist about psychosocial distress, 17% recalled receiving detailed
information about the POS (Table 2). Frequencies of talking and
informing were similar in patients with low and high distress
(Table 2). However, almost twice as many patients with high distress
(30%) than patients with low distress (16%) said they were given a
recommendation for POS.
3.3 | Predictors of POS uptake
The multivariate logistic regression analysis (Table 3) showed that
patients who reported receiving a recommendation from their oncol-
ogist (recommending: yes) and patients who were not sure if they
received a recommendation (recommending: do not know) were more
likely to attend the POS than patients who did not report a recom-
mendation from their oncologist in the first consultation
(recommending: no). Younger patients, patients with high distress
values, and patients with high education were more likely to attend
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the POS. POS uptake was not predicted by a patient's report that
the oncologist had discussed psychosocial distress of the patient
(talking) or that the oncologist had given detailed information
(informing) about the POS. Gender and oncological treatment intent
(curative vs palliative) did not predict POS uptake. These associa-
tions did not change if only the three communication variables were
included into the model (Table S1). We found no interaction effect
between distress and oncologist recommendation (data not shown).
There was no difference in POS uptake in higher compared to lower
distressed patients reporting a recommendation from their
oncologist.
4 | DISCUSSION
In this study, we examined predictors of POS uptake, focusing on var-
iables of the patient‐oncologist communication. As we hypothesized,
patients who reported an oncologist recommendation were much
more likely to use POS than patients who did not report an oncologist
recommendation. Patients who were unsure if an oncologist gave
TABLE 2 Frequencies of patient's reports of the patient‐oncologist
communication in all patients (n = 333) and in subgroups of high dis-
tressed (n = 152) and low distressed (n = 132) patients
All
Patients
(n = 333)
High
Distressed
Patients
(n = 152)
Low
Distressed
Patients
(n = 132)
Answer n (%) n (%) n (%)
Talking Yes 179 (54%) 80 (53%) 73 (55%)
Do not know 38 (11%) 18 (12%) 14 (11%)
No 116 (35%) 54 (36%) 45 (34%)
Informinga Yes 58 (17%) 29 (19%) 21 (16%)
Do not know 95 (29%) 43 (28%) 40 (30%)
No 179 (54%) 79 (52%) 71 (54%)
Recommendingb Yes 75 (23%) 45 (30%) 21 (16%)
Do not know 48 (14%) 21 (14%) 19 (14%)
No 208 (63%) 86 (57%) 91 (70%)
Talking (“Did the oncologist talk about your psychosocial distress with
you?”); informing (“Did the oncologist inform you about how the psycho‐
oncologist can provide support?”); recommending (“Did the oncologist rec-
ommend that you attend the psycho‐oncology service?”).
a1 missing answer.
b2 missing answers.
TABLE 3 Multivariate logistic regression analysis using patient‐
related variables (sociodemographic and clinical variables) and patient‐
oncologist communication variables (talking, informing,
recommending) to predict POS uptake
Wald OR 95% CI P Value
Communication variables
Talking (yes vs no) −0.87 0.74 0.38‐1.46 0.387
Talking (do not know vs no) 0.38 1.21 0.45‐3.13 0.701
Informing (yes vs no) 0.14 1.06 0.46‐2.38 0.887
Informing (do not know vs no) −1.16 0.62 0.27‐1.37 0.245
Recommending (yes vs no) 5.13 6.27 3.14‐12.85 <0.001**
Recommending (do not
know vs no)
3.22 4.64 1.83‐11.97 0.001**
Patient‐related variables
Age (per 10 years) −2.31 0.78 0.63‐0.96 0.021*
Gender (female) −0.46 0.87 0.48‐1.58 0.643
Education (high) 1.97 1.87 1.01‐3.50 0.048*
Treatment intent (palliative) 0.78 1.27 0.69‐2.33 0.437
Distress (per unit, 0‐10) 3.99 1.28 1.14‐1.45 <0.001**
n = 330, Nagelkerke's R2 = 0.295, C‐statistic = 0.80.
Abbreviations: POS, psycho‐oncological service; B, beta‐coefficient; SE,
standard error; Wald, Wald‐statistic; OR, odds ratio; CI, confidence inter-
val; P value, significance level; R2, Nagelkerke's R2; C, C‐statistic.
*P value <0.05.
**P value <0.01.
TABLE 1 Sociodemographic and clinical characteristics of partici-
pants (n = 333, unless otherwise stated)
n (%)
Age, in years
Mean (SD) 60.5 (14.0)
Range 19‐93
Gender
Female 151 (45.3)
Male 182 (54.7)
Education
Nonacademic 217 (65.2)
Academic (diploma/university degree) 116 (34.8)
Distress thermometera
DT score 0‐4 132 (46.5)
DT score 5‐10 152 (53.5)
Oncological treatment intent
Palliative 128 (38.4)
Curative 205 (61.6)
Time after initial cancer diagnosis, in weeks
Median (range) 4 (0‐264)
Cancer typeb
Breast cancer 67 (20.1)
Thoracic malignancies 59 (17.7)
Hematologic malignancies 51 (15.3)
Genitourinary cancer 28 (8.4)
Melanoma/skin cancer 27 (8.1)
Gastrointestinal (noncolorectal) cancer 22 (6.6)
Central nervous system tumours 16 (4.8)
Others 64 (19.2)
Current oncological treatments (multiple treatments possible)
Systemic treatmentc 298 (89.5)
Radiotherapy 109 (32.7)
Surgery 34 (10.2)
No treatment/watch and wait/others 21 (6.3)
Abbreviations: SD, standard deviation; DT, distress thermometer.
an = 284, DT information from 49 patients were missing due to nondeliv-
ery of the DT by clinical staff (n = 18), not being provided by patients
(n = 22), and lost documents (n = 9).
bOne participant with two cancer types.
cSystemic treatment includes chemotherapy, immunotherapy, hormone
therapy, and targeted therapy.
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them a recommendation were also more likely to attend POS than
patients who did not report an oncologist recommendation. Contrary
to our hypotheses, patients who reported receiving detailed informa-
tion about POS (informing) or who reported discussing their psychoso-
cial distress (talking) were not more likely to attend POS. We found
that high distress levels predicted POS uptake10-12 along with age
and educational level,10,12,15-17 but found no association between
female gender or palliative treatment intent and POS uptake.
First and importantly, we found a strong association between the
report of an oncologist's recommendation for POS and uptake, con-
trolling for patients' distress level. This finding suggests that the oncol-
ogist's judgment that psycho‐oncological support is necessary for the
patient considerably influences a patient's uptake of support. Patients
might trust the oncologist's judgment since in German‐speaking coun-
tries, oncologists are central in the referral of POS.31 Moreover, it has
been suggested that in the context of a life threatening disease the
clinical relationship arises primarily from patients' appreciation of the
clinicians' expertise in a phase of vulnerability. The intensity of the
patient to clinician rapport after one meeting was shown to be
strong.32 Additionally, recommendations might carry more weight
than complex information about what psycho‐oncologists do or
talking about individual distress because they are easier for patients
to process. The semantic clarity an oncologist's recommendation pro-
vides may be particularly important in a first outpatient consultation,
since these consultations typically are loaded with new and potentially
stressful information. When patients are under emotional stress, their
cognitive capacity to process and recall information in oncological
consultations may diminish,25,33,34 and the majority of patients in our
study were under emotional stress prior to their first oncological con-
sultation. Thus, distress levels in our study were higher compared with
other studies.16,18 However, in most studies, distress was not assessed
prior to the first consultation but at home or at any time at the clinic.
We were surprised to find that patients who were unsure if they
had received a recommendation from their oncologist were also more
likely to use POS. It is possible that these patients were given a rec-
ommendation which influenced their choice, but could not remember
it clearly in the interview.35 It is also possible that the patients
received a recommendation but could not remember if it came from
the oncologist in the first consultation or from another source inside
the clinic (eg, written information on the DT, nurses, other involved
health care providers) or outside the clinic (eg, spouses, friends). Addi-
tionally, a patients' attitude towards POS might also affect their mem-
ory.10,12,14 Patients with positive or rather neutral attitudes towards
POS may be more able to recognize a recommendation from their
oncologists. Patients with a more negative attitude towards POS will
probably verbalize their psychosocial concerns and support needs less
explicitly. Finally, oncologists may initiate discussions and provide
referral more often if they perceive more explicit and more frequent
cues of psychosocial concerns.36 It should be emphasized that
oncologists were instructed to treat all patients equally within the
referral process, yet adapted information provision and recommenda-
tion to patients individually. Since a naturalistic interaction and a
patient‐tailored referral was the aim, there was also a certain latitude
of oncologist behaviour in the referral pathway regarding
recommendations.
Moreover, we found that patients who reported talking about
psychosocial distress with their oncologist in the first consultation
did not take advantage of POS more frequently. However, oncologists
and patients may have different views of what it means to have talked
about psychological distress. A study by Mackenzie et al37 showed
that almost half of the patients who did not want to talk about their
distress with their oncologist said that other issues were more impor-
tant to them in an oncological consultation, which aligns with our find-
ings that only half of the patients in our study reported having a
conversation about psychosocial issues during their consultation.
Further, we found that patients who reported having received
detailed information about what psycho‐oncologists do did not more
frequently take advantage of POS. In fact, less than one‐fifth of
patients reported having received detailed information from their
treating oncologist in the first consultation. Again, oncologists and
patients might have different views of what detailed information
about POS means, and the stressful situation may have affected
patients' ability to process and recall this information.33,34 Probably,
the complexity of the information did not meet the situational need
of the patient and patients may be more likely to remember detailed
information about POS if it was disseminated in a later appointment.
Like previous studies, we found that high distress levels pre-
dicted POS uptake10-12 as did patient characteristics like age and
educational level.10,12,15-17 Like some other studies, we found no
association between gender and POS uptake.38,39 POS uptake was
also not associated with oncological treatment intent (curative vs
palliative), that corresponds to other studies18,19 which reported
no association between treatment intent and wish for referral.
We determined treatment intent from patients' medical records
instead of asking patients for their perception, yet patients' percep-
tion of the treatment goal often differs from the oncologist's
perception,25 and we assume that the individual perspective of
patients is key for patients' uptake behaviour. Furthermore POS
uptake is not the unique or exclusive manner of addressing
patients' distress. Patients may already have their individual coping
mechanisms or self‐management strategies which they prefer and
may be more effective for them.6 Therefore, a patient‐oriented
approach should be considered in stepped care systems to tailor
support to patients' needs.
4.1 | Clinical implications
Our results indicate that in a stepped psycho‐oncological care model
in which oncologists triage patients, their expert recommendations
strongly affect patients' decisions to use POS. Because of their influ-
ence, oncologists need to act sensitively and responsibly to help
patients overcome barriers to use POS. Oncologists should take
patient‐related factors into account when making recommendations,
and pay special attention to the needs of older patients and less edu-
cated patients because patients in these groups are less likely to take
advantage of POS. Because giving patients detailed information about
POS was not associated with POS uptake, it may be better to provide
detailed information in later consultations. Giving information and
discussing distress should not be omitted even though for the
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analysed target (uptake) we do not have evidence of a predictive
power. However, these two aspects are essential for the empower-
ment of patients and belong to a contemporary and comprehensive
patient care. In any case, findings of the present analyses call for
stronger interdisciplinary collaboration and demand further investiga-
tions of how patients experience communication with health care
providers.
4.2 | Study limitations
Our study has several limitations. First, we have no objective record
of the consultations and, thus, did not capture what happened
between the patient and oncologist. We decided against audio or
video recording because we would have had to include patients
before their first visit and we expected this to cause major recruit-
ment problems Social desirability, recall biases, and oncologist bias
have to be considered as sources of bias of the reports.25,40 The lack
of objective records limits our understanding of what leads to
patients to being unsure of whether or not an information had been
given and how comprehensibly oncologists verbalized a recommenda-
tion and on what grounds. Because oncologists' workload and terms
of employment were not comparable, we could not control for rec-
ommendation rate. However, in our study, we chose to focus on
patients' subjective reports, which we consider key for their actual
behaviour. Second, this is a monocentre observational study con-
ducted at a Swiss comprehensive cancer centre, with cultural partic-
ularities regarding the strong position of the oncologist in the
coordination of psychosocial care.31 Hence, our centre might not rep-
resent other outpatient oncological settings that integrate POS into a
stepped‐care model where the treating oncologist generally
addresses psychosocial issues.22 However, our sample included a
large gender‐balanced sample of cancer patients, a broad array of
cancer types, and the POS uptake rate was comparable to other out-
patient oncological settings.11 Third, due to ineligibility criteria, our
findings are not representative for patients who are not fluent in Ger-
man or who are cognitively and physically very impaired. Thirteen per
cent of all eligible patients were not informed about the study, 28%
of eligible patients refused information about the study, and 12%
refused participation. Our recruitment strategy was designed to
reduce the stigma of accepting an invitation to participate in a
psycho‐oncological study, but there is a risk of selection bias if oncol-
ogists informed only patients who were considered to be interested
or healthier. Also, it is possible that patients who declined study par-
ticipation are in general less interested in psychological content and
would decline the usage of POS, that potentially could interfere with
the representativeness of the enrolled patients. However, declining
patients could also be psychologically too burdened but yet inter-
ested in POS offers. Taking ethical considerations into account we
demanded two detailed interviews from patients in a vulnerable state
of health. However, we were careful in seeking information and not
overtaxing patients; the study team and all oncologists were sensi-
tized to prioritize patients' health, and the study was carefully
approved by the local ethics committee.
5 | CONCLUSION
Reported oncologists' expert recommendations to attend POS were
strongly associated with patients' uptake of POS. The central role
oncologists play for POS uptake should be accounted for in stepped
psycho‐oncological care when POS referral pathways are defined.
Also, oncologists should pay attention to the needs of older patients
and less well‐educated patients. Because receiving detailed informa-
tion about POS did not result in more POS uptake, it may be better
to provide detailed information in later consultations.
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Supplementary Table 1. Multivariate logistic regression analysis using patient-oncologist 
communication variables (talking, informing, recommending) to predict POS uptake. 
 B (SE) Wald OR 95% CI p-value 
Communication variables      
Talking (yes vs no) -0.27 (0.3) -0.84 0.76 0.40–1.44 0.402 
Talking (don't know vs no) 0.04 (0.5) 0.08 1.04 0.40–2.55 0.933 
Informing (yes vs no) 0.30 (0.4) 0.78 1.35 0.63–2.83 0.436 
Informing (don't know vs no) -0.41 (0.4) -1.06 0.66 0.30–1.39 0.287 
Recommending (yes vs no) 1.77 (0.3) 5.46 5.88 3.13–11.22 <0.001** 
Recommending (don't know vs no) 1.41 (0.4) 3.23 4.10 1.74–9.74 0.001* 
Note. n=330, Nagelkerke's R²=0.170, C-statistic=0.73. 
Abbreviations. POS, psycho-oncological service; B, Beta-coefficient; SE, standard error; Wald, Wald-
statistic; OR, odds ratio; CI, confidence interval; p-value, significance level; R², Nagelkerke's R²; C, C-
statistic.  
* p-value <0.05; ** p-value <0.01. 
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4.3 Talking about psychosocial distress screening: what oncologists and cancer 
patients recall 
 
Tondorf, T., Rothschild, S.I., Koller, M.T., Rochlitz, C., Kiss, A., Grossman, P., & 
Zwahlen, D. Talking about psychosocial distress screening: what oncologists and cancer 
patients recall. (under review in Supportive Care in Cancer) 
Purpose. The aim of this study was to assess how oncologists use psychosocial distress 
screening procedures and to compare cancer patient and oncologist recall regarding 
communication about distress and support in clinical oncology. Methods. Patients were 
screened for psychosocial distress with the Distress Thermometer (DT) before their first 
consultation in an oncology outpatient clinic. Oncologists (n=25) discussed distress and 
support options with patients (n=333). After the consultation, oncologists used a questionnaire 
to evaluate the screening procedure and conversation. In a semi-structured interview, patients 
recalled their perceptions of the conversation. Results. Oncologists primarily used the DT in 
the first consultation to initiate communication about psychosocial distress. Whereas 
oncologists reported addressing distress during 96.6% of all consultations, 53.8% of the 
patients recalled any discussion of this topic. Higher age, greater distress, and attaching less 
importance to talking about distress with the oncologist predicted patients' failure to remember 
that distress had been addressed. Although oncologists reported providing detailed 
information about psycho-oncological support in 89.9% of consultations, 18.2% of the patients 
had any recollection of such information. Oncologists recommended 56.6% of patients to 
attend the psycho-oncology service, whereas 23.7% of the patients recalled a recommendation. 
Conclusions. Oncologists and patients differed substantially in recall of communication about 
psychosocial distress. Oncologists attempted to use the DT more to initiate communication 
about distress than as an assessment tool. However, patients often failed to register this 
communication. For an improved psychosocial care in oncology, distress-screening programs 
must consider new approaches to enhance patient-clinician communication. Keywords: 
cancer, distress screening, patient-clinician communication, psychosocial care, recall
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INTRODUCTION 
Psychosocial distress screenings are used in routine oncology practice to help clinicians 
rapidly identify cancer patients whose level of psychosocial distress is high, and to initiate 
referral to psychosocial services [1-3]. Screening programs have been implemented as an 
international standard for comprehensive care of cancer patients, and are mandatory for 
institutional certification as a Comprehensive Cancer Center in many countries [3-5]. 
However, the validity and usefulness of these screenings have been questioned in clinical 
practice [6, 7]. Clinical practice and research show that severity of distress is not the only 
factor influencing whether or not a patient accepts a referral to psychosocial services [8-
10]. Many patients who have high distress-screening scores refuse psychosocial support, 
whereas some patients with lower distress levels seek out support [10-12].  
If clinicians are to understand the patient’s needs and encourage highly distressed 
patients to accept potentially helpful psychosocial services, clinicians and patients must 
effectively communicate [5, 13]. Successful patient–clinician communication can reduce 
anxiety and depression in cancer patients [14, 15], improve their satisfaction with care 
[16], change their beliefs and raise adherence to cancer treatments [17], and encourage 
patients to seek additional support [18]. However, there is evidence of alarming levels of 
lack of recall of relevant medical information among patients during oncological 
consultations [19, 20]. Intensity of emotions, cognitive complexity, and ambiguity may all 
cause misunderstanding during communication between patient and clinician, that may 
influence access to and acceptance of psychosocial support [13].  
We know of no study that has assessed differences between patients' and clinicians' 
recall of conversations about psychosocial distress and psycho-oncological support after 
distress screening during the first consultation of routine oncology practice.  
Our study had two aims: 1) to study the approaches by which oncologists used the 
Distress Thermometer (DT) to assess psychosocial distress, communicate about 
psychosocial distress and support options, and refer patients to psychosocial services, and 
2) to compare patients' and oncologists' recall of their perceptions of the conversation. 
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PATIENTS AND METHODS 
We conducted a prospective, observational study in the Oncology Outpatient Clinic of the 
University Hospital Basel in Switzerland. The methods are outlined below and are 
described in more detail in the study protocol [21]. 
Participants 
All cancer patients who presented for the first time at the Medical Oncology Outpatient 
Clinic at the University Hospital Basel (Switzerland) were pre-screened for eligibility and 
interest to join the study by their attending oncologist (“Are you interested to participate 
in a psycho-oncological study assessing reasons for accepting psycho-oncological 
support?”). To be included, patients needed to be 18 years or older, fluent in German, 
physically and cognitively well enough to participate, and to have planned at least one 
additional consultation.  
Standard Screening Procedure 
Cancer patients are routinely screened at their first outpatient consultation for 
psychosocial distress, based on a stepped–care model [3]. Patients receive the DT in the 
waiting room. The back side of the DT describes the available in-house psycho-oncology 
service. Oncologists are instructed to address psychosocial distress and to provide 
information about the psycho-oncology service to all patients in the first consultation. 
They are advised to recommend the service to patients who have a clinically relevant level 
of distress (DT≥5), or based on their clinical judgment, or the patient's wish. Oncologists 
were trained in how to communicate about psychosocial distress and how to follow 
guidelines for referral to the psycho-oncology service. 
Study Procedure 
After pre-screening by attending oncologists, the study team informed eligible and 
interested patients about the study details and procedure. Subsequent to receiving 
informed consent, participants were interviewed by a member of the study team on 
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average 15 days (range 0–46 days) after the first consultation. Patient preference 
determined whether interviews were conducted via telephone (44%) or face-to-face 
(56%). An interview manual was used in all cases. Oncologists separately completed a 
paper-pencil questionnaire. This study complied with the Declaration of Helsinki. The 
local ethics committee approved the study (Ethikkommission Nordwest- und 
Zentralschweiz, Ref.Nr.: EK220/13).  
Measures 
Characteristics of patients and oncologists. We recorded patients' sociodemographic data 
in an interview and collected clinical data from their medical records. Oncologists reported 
their personal data in a questionnaire. 
Psychosocial distress screening. To screen for self-reported psychosocial distress, we used 
the German version of the DT with the problem list [22]. The one-item DT (“How much 
distress have you been experiencing in the past week including today?”; scale from 0 "no 
distress" to 10 "extreme distress") has a cutoff value of 5 for clinically significant levels 
of distress. The problem list has five problem categories and 36 items to identify potential 
causes of distress. Baseline distress levels were assessed during the interview with the 
same question “How much distress have you been experiencing in the past week including 
today?” (scale from 0 "no distress" to 10 "extreme distress"). 
How oncologists used the DT. Oncologists were asked: "How helpful was the DT in the 
consultation with the patient?" (scale from 0 "not helpful at all" to 10 "very helpful"). They 
could choose among six reasons for using the DT (multiple answers possible): The DT 
was helpful 1) to assess the patient's distress; 2) to assess the patient's problems; 3) to 
initiate the conversation about psychosocial distress; 4) to structure the conversation about 
psychosocial distress; 5) for referral to the psycho-oncology service; and 6) for referral to 
social or pastoral care. 
How oncologists and patients perceived the conversation. Oncologists and patients were 
asked four questions to assess communication about psychosocial distress and the psycho-
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oncology service (Table 1). Oncologists' reasons for not talking about psychosocial 
distress and for not recommending the psycho-oncology service were recorded in open-
ended questions. Patients were also asked: "How important was it for you to talk about 
your psychosocial distress with the oncologist?" (scale from 0 "not important at all" to 10 
"very important"). 
Data Analysis 
We assessed patients’ and oncologists’ recall of the conversation as cross-tabulation of all 
paired observations. We used multivariate logistic regression analysis to predict patients' 
failure to recall 'talking about psychosocial distress' (recall (yes)=0; failure to recall (no/ 
don't remember)=1). The oncologist was used as a random coefficient to account for 
potential within–oncologist clustering. We used robust standard errors to compute P-
values and 95% confidence intervals. Predictor variables were patients' age (10-years 
increase), patients' distress level at the first consultation, the importance patients attach to 
talking about psychosocial distress with the oncologist, and time between first consultation 
and study interview (1-week increase). Missing data of patients' screening distress level 
(n=46) were imputed with patients’ baseline distress levels. Missing data of patients’ 
importance of talking (n=43) were imputed using multiple imputation method. 
Significance level was set at P ≤ .05. Results were calculated with SPSS version 22 (IBM, 
Armonk/NY, 2013). 
 
RESULTS 
Between October 2013 and January 2016, 1,261 patients newly registered at the clinic, of 
whom 21 patients had no malignant tumor. Patients were excluded from the study due to 
insufficient German (n=164), insufficient performance status or cognitive status (n=125), 
or no further consultation (n=195). Oncologists did not inform 99 patients about the study 
due to lack of time (n=8), neglect (n=11), difficult consultation (n=59) or other reasons 
(n=21). Of the remaining 657 eligible cancer patients, 209 declined to participate in a 
  55 
psycho-oncological study and 15 patients could not be reached. The study team 
approached and completely informed 433 patients about the study course, of whom 37 
patients declined to participate, 38 were too highly distressed, 19 gave other reasons, and 
6 could not be analyzed due to too many missing data. In total, 333 patients (77% of all 
approached patients) completed the study.  
Sociodemographic and Clinical Characteristics 
Psychosocial distress was normally distributed among participants; 53.5% of participants 
showed clinically significant psychosocial distress (DT≥5; Table 2).  
Twenty-five oncologists participated in the study (professional seniority 0–30 years): 13 
men and 12 women; mean age 36.6 years (range 28–58 years); nine senior oncologists 
(professional seniority ≥6 years); six oncologists in training (professional seniority ≤4 
years); and ten resident oncologists (professional seniority ≤2 years).  
How Oncologists Used the DT 
In 65.5% of all evaluable consultations (n=278), oncologists rated the DT as helpful or 
neutral (values 5–10). Answers from 55 consultations were missing (problems with DT 
delivery by clinical staff, n=18; not being provided by patients, n=22; missing answers 
from oncologists, n=6; lost documents, n=9). Oncologists evaluated DT usefulness for 207 
consultations and gave three main reasons: The DT helped initiate the conversation about 
psychosocial distress (58.0%); it helped assess the patient's distress (45.9%); and it helped 
suggest a referral to the psycho-oncology service (25.1%). Other answers were given in 
fewer than 17% of consultations. 
How Oncologists and Patients Perceive the Conversation  
Oncologists reported talking with their patients about psychosocial distress in 96.6% of 
consultations (Figure 1); 53.8% of the patients remembered the conversation (patient-
oncologist agreement 51.8%; Table 3). The only reason oncologists gave for not broaching 
the subject was lack of time. Oncologists informed 97.5% of all patients about the 
existence of psycho-oncology service, and 84.1% of the patients affirmed (patient-
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oncologist agreement 82.2%). Oncologists provided detailed information about the benefit 
of psycho-oncological support to 89.9%; 18.2% of the patients remembered detailed 
information (patient-oncologist agreement 16.6%). Oncologists recommended 56.6% of 
all patients across all distress levels to make use of the psycho-oncology service (73.8% 
of patients with high distress [DT≥5]; 38.9% of patients with low distress [DT<5]; Figure 
2), and 23.7% of all patients remembered (patient-oncologist agreement 17.5%). The 
reasons oncologists gave for not recommending the service to patients with high distress 
were (in order of frequency): “The patient… 'receives sufficient social support', 'already 
receives psychological/psychiatric support', 'distress level seems lower than indicated on 
the DT', 'shows no perceivable need for support', 'declines psycho-oncological support for 
now/ in general', 'has a curative treatment approach'.” 
Predictors of Patients' Failure to Recall Talking about Psychosocial Distress 
Patients failed to remember the discussion about psychosocial distress with the oncologist 
in 46.2% (n=154) of cases. Predictors of patients' failure to recall were higher age (odds 
ratio [OR]=1.36; 95% confidence interval [CI], 1.13-1.64; P = .001), higher psychosocial 
distress (OR=1.12; 95% CI, 1.02-1.23; P = .021), and attaching less importance to talking 
about psychosocial distress with the oncologist (OR=0.83; 95% CI, 0.76-0.89; P < .001). 
Time between the first consultation and recall in the interview did not predict patients' 
failure to recall (OR=1.13; 95% CI, 0.95-1.34; P = .175). 
 
DISCUSSION 
In our investigation, oncologists indicated that they had used distress screening more to 
initiate the conversation about psychosocial distress than for actual screening purposes 
and that they had addressed the subject of psychosocial distress in almost all initial 
outpatient consultations. Patients, on the other hand, failed to recall much of the 
information oncologists reported to have shared.  
In two-thirds of all consultations, oncologists in our study considered the DT helpful 
for clinical practice. Why in the other third of consultations oncologists did not perceive 
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the DT as helpful remains unclear. Nevertheless, oncologists in our study reported that 
they had addressed psychosocial distress in almost all initial consultations and provided 
information about the in-house psycho-oncology service, as well as details of psycho-
oncological support. Contrary to current guidelines [3], oncologists in our study did not 
recommend the psycho-oncology service to all highly distressed patients; additionally they 
did recommend the service to some patients with low distress scores. For oncologists, 
factors other than the level of distress on the DT (e.g. the patient was already receiving 
sufficient social support) may have influenced their decision of whom to give or withhold 
a recommendation.  
Half of all cancer patients did not remember psychosocial distress being discussed at 
all. Predictors of patients' failure to recall having talked about psychosocial distress were 
higher age, higher distress level at first consultation, and attaching less importance to 
talking about psychosocial distress with the oncologist. In addition, only one fourth of all 
patients recalled that the oncologist had provided a recommendation, and only a fifth 
remembered details of the benefits of psycho-oncological support having been provided 
by the attending oncologist. However, most patients did recall the information about the 
in-house psycho-oncology service. Since this information was relatively simple and was 
given both orally by the oncologist and in written form on the back side of the DT, it is 
possible that combining written and oral information may make it easier for patients to 
remember. 
Research on communication in cancer care has shown that patients miss a remarkable 
amount of the information presented to them by their clinicians [19]. The stress that 
accompanies bad news may cause the patient’s attention to narrow focus to the information 
they find most pressing [23]. Additionally, the importance patients attach to addressing 
psychosocial distress depends on contextual factors like the treatment trajectory and goal 
[24]. Also, Jansen et al. [25] found that recall of information significantly decreases with 
age. Patients and oncologists may, furthermore, have different understandings and 
different expectations when discussing distress [26, 27], and may vary in perceptions 
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regarding recommendations and explanations of psychosocial support. Oncologists may 
underestimate the complexity of the detailed information they deliver, and overestimate 
the capacity of a patient to remember it [28].  
Our results, like those of others [2, 29, 30], emphasize that distress-screening tools 
create an opportunity for clinicians to initiate the communication about psychosocial 
distress with cancer patients. According to Epstein and Street [13] an effective patient–
clinician communication is reached by aligning patients' and clinicians' perspectives by 
making needs, goals, and expectations explicit early in the clinical encounter. This requires 
cooperation, knowledge, and skills from clinicians, making a communication training 
crucial [13, 31]. 
Our study has several strengths and limitations. Although our results represent real-
life oncology practice, it is a single-center study conducted in one major Swiss university 
medical center. Single-center studies are common in the medical literature [19, 32, 33] 
and may provide valuable heuristic information. However, they may not prove 
representative of the majority of institutional settings, are likely to reflect national and 
cultural variations, and therefore require international multicenter replication. 
Furthermore, due to the particulars of our recruitment process, oncologists did not inform 
13% of all eligible patients about the study, and in the pre-screening 30% of all eligible 
patients declined further information about the purpose and course of the study. Therefore, 
43% of all eligible patients were not approached for study participation. This procedure 
may have caused a selection bias. However, 77% of all approached patients completed the 
study.  
Regarding strengths, our investigation is, in fact, one of few psychological studies that 
has recruited patients in the period of increased vulnerability awaiting cancer treatment 
[3] and is the first study focusing on the content of patient–clinician communication during 
a standard distress-screening procedure. Because of the original character of our results, it 
should be interpreted carefully, and replication is necessary.  
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Another strength is that the study incorporates subjective perspectives of both patients 
and oncologists. However, because we did not record patient–oncologist consultations 
because we did not want to disrupt the first consultation, we only know what oncologists 
and cancer patients reported. Here again, because adherence to standard screening 
procedures can differ across clinics [34, 35], our results may not be generalizable to other 
settings.  
For an improved psychosocial care in oncology, the clinical distress screening pathway 
may require some rethinking [7, 36]. The acceptability of psychosocial care depends very 
much on the communication between patients and clinicians [31]. Therefore, distress-
screening programs must consider new approaches to enhance patient-clinician 
communication 1) by training oncologists to effectively communicate about psychosocial 
distress and psychosocial health needs, 2) by promoting greater cognizance of the various 
individual and contextual factors that can influence information processing among patients 
(e.g. older age, high initial distress), and 3) by repeating the conversation about 
psychosocial distress and support options at different phases of oncological treatment and 
with different modes (e.g. combine oral and written information). Overall, the clinical 
distress screening pathway might benefit from detailed recommendations to guide 
clinician interaction and communication with the patient. 
To conclude, we examined patient–clinician communication during a standard distress 
screening procedure. From the oncologist’s perspective, the distress screening helped 
them recognize and initiate communication about psychosocial distress. However, we 
found that patients failed to recall much of the information oncologists reported to have 
shared. 
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TABLES 
Table 1. Oncologists' and Patients' Perception of their Conversation. 
Variables Oncologists'           Questionnaire            
Patients' Interview 
Questions 
Talking about 
Psychosocial Distress 
Q: "Did you talk with the 
patient about his/her 
psychosocial distress?"  
Q: "Did the oncologist talk 
about your psychosocial 
distress with you?"  
  A: Yes/ No A: Yes/ No/ Don't remember 
Information about the 
Psycho-Oncology 
Service 
Q: "Did you inform the 
patient about the psycho-
oncology service?" 
Q: "Did the oncologist inform 
you about the psycho-
oncology service?" 
  A: Yes/ No A: Yes/ No/ Don't remember 
Detailed Information 
about Psycho-
Oncological Support 
Q: "Did you inform the 
patient about how the 
psycho-oncologist can 
provide support?" 
Q: "Did the oncologist inform 
you about how the psycho-
oncologist can provide 
support?" 
  A: Yes/ No A: Yes/ No/ Don't remember 
Recommendation to 
Attend the Psycho-
Oncology Service 
Q: "Did you recommend 
that the patient attends the 
psycho-oncology service?" 
Q: "Did the oncologist 
recommend that you attend 
the psycho-oncology 
service?" 
  A: Yes/ No A: Yes/ No/ Don't remember 
Q, question; A, answer format. 
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Table 2. Participants' Sociodemographic and Clinical Characteristics (n=333, unless otherwise 
stated)  
  n   % 
Age, in years     
Mean (SD) 60.5 (14.0) 
Range 19-93 
Sex     
Female 151  45.3 
Male 182  54.7 
Education     
Low (9th grade or less) 31  9.3 
Middle (apprenticeship/ high school) 186  55.9 
High (diploma/ university degree) 166  34.8 
Living with a partner     
Yes 233  70.0 
No 100  30.0 
Living with children     
Yes 72  21.6 
No 261  78.4 
Distress Thermometer*      
DT score 0-4 132  46.5 
DT score 5-10 152  53.5 
Mean (SD) 4.7 (2.7) 
Cancer type°   
Breast cancer 67  20.1 
Thoracic malignancies 59  17.7 
Hematologic malignancies 51  15.3 
Genitourinary cancer 28  8.4 
Melanoma/ skin cancer 27  8.1 
Gastrointestinal (non-colorectal) cancer 22  6.6 
Central nervous system tumors 16  4.8 
Colorectal cancer 15  4.5 
Head and neck cancer 14  4.2 
Sarcoma 13  3.9 
Gynecologic cancer 5  1.5 
Others 17  5.1 
Time after initial cancer diagnosis, in weeks    
Median (range) 4 (0-264) 
Current oncological treatments (multiple treatments possible)   
Systemic treatment§ 8  89.5 
Radiotherapy 109  32.7 
Surgery 34  10.2 
No treatment/ watch and wait/ others 21  6.3 
Oncological treatment intent     
Palliative 128  38.4 
Curative 205  61.6 
Tumor staging     
Local 92  27.6 
Locally advanced 84  25.2 
Metastatic 105  31.5 
Other 52  15.6 
ECOG     
0-1 291  87.4 
≥ 2 42   12.6 
Abbreviations. SD, standard deviation; DT, Distress Thermometer; ECOG, index of 
performance status (lower values indicating better performance status) 
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*n=284, DT information from 49 patients were missing due to non-delivery of the DT by 
clinical staff (n=18), not being provided by patients (n=22), and lost documents (n=9) 
°n=334, one participant with two cancer types 
§Systemic treatment includes chemotherapy, immunotherapy, hormone therapy, and targeted 
therapy 
 
Table 3. Oncologists' and Patients' Recall of their Conversation§.  
Talking about Psychosocial Distress* (n=326) Detailed Information about the Psycho-Oncology Service* (n=313) 
  Oncologist   Oncologist 
  Yes No   Yes No 
Patient 
Yes 169 (51.8%) 5 (1.5%) 
Patient 
Yes 52 (16.6%) 4 (1.3%) 
No 108 (33.1%) 6 (1.8%) No 152 (48.6%) 14 (4.5%) 
Information about the Psycho-Oncology Service* (n=326) Recommendation to Attend the Psycho-Oncology Service* (n=302) 
  Oncologist   Oncologist 
  Yes No   Yes No 
Patient 
Yes 268 (82.2%) 7 (2.1%) 
Patient 
Yes 53 (17.5%) 20 (6.6%) 
No 21 (6.4%) 1 (0.3%) No 94 (31.1%) 96 (31.8%) 
 
Note. *Patient does not remember: Talking (n=38, 11.7%); Information (n=29, 8.9%); Detailed Information (n=91, 29.1%); 
Recommendation (n=39, 12.9%) §Questions are listed in Table 1. 
 
 
 
 
 
FIGURES 
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Fig. 1 Descriptive diagram of oncologists' perception and patients' perception of their 
conversation in the first ambulatory consultation on four variables (questions are listed in 
Table 1). Oncologists’ and patients’ data are separated from each other, each column 
representing oncologists or patients’ view. Blue indicates oncologists or patients recall that 
they have talked about this issue. Dark grey indicates oncologists or patients recall that 
they have not talked about this issue. Light grey indicates patients don’t remember if they 
have talked about this. Number of consultations (n) varies because of missing data 
 
 
Fig. 2 Percentage of recommendations from oncologists to attend the psycho-oncology 
service (blue: oncologist gave a recommendation; grey: oncologist gave no 
recommendation) to patients with low psychosocial distress (DT<5, n=126) and high 
psychosocial distress (DT≥5, n=145) 
Abbreviations. DT, Distress Thermometer
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5   Discussion 
5.1 Summary of findings 
 
To understand the health care needs of cancer patients, we conducted a longitudinal, 
observational mixed-methods study with prospective data to assess distress, intention, and 
uptake of the psycho-oncology service. From the patient’s perspective, severity of 
psychosocial distress was one (but not the only) determinant of patients’ intention to 
accept psycho-oncological support. Other factors that shaped cancer patients’ intentions 
included attitude to psychological support, coping strategies, and perceived social and 
professional support. We found that one-third of all cancer patients were ambivalent about 
using the psycho-oncology service. These patients also reported high distress values on 
the DT and were generally open to psychological support. However, a majority of 
ambivalent patients did not attend the outpatient psycho-oncology service over a period 
of four months. In total, a quarter of all participating patients attended the psycho-
oncology service over a four-month period. Factors predicting actual uptake included 
younger age, higher education, and higher distress levels. However, the strongest predictor 
of uptake was oncologists’ recommendation to attend the psycho-oncology service.  
From the oncologist’s perspective, DT was found to be helpful in two-thirds of all 
consultations, using the screening tool principally to open the door to a conversation about 
psychosocial issues. In almost all cases, the oncologists addressed the issue of 
psychosocial distress and provided information about the outpatient psycho-oncology 
service. However, patients often failed to recall this conversation. Higher age, higher 
initial distress, and attaching less importance to talk about distress with the oncologist 
predicted patients’ failure to remember. 
 
 
  67 
5.2 Discussion and integration  
 
Cancer is a potentially life-threatening disease attended by adverse effects on physical and 
psychological well-being. Many cancer patients who might benefit from psychosocial 
support fail to attend these services. The study aimed to understand the health care needs 
of cancer patients (cf. Figure 2) and to reduce any barriers to referral to supportive care 
services.  
For uptake of psychosocial care, information about supportive care services is a 
prerequisite, and lack of information is therefore a barrier (Dilworth et al., 2014; Mosher 
et al., 2014; Neumann et al., 2010). As in other outpatient oncological settings that use a 
stepped model of psycho-oncological care (Singer et al., 2017), all participating patients 
in our study were supplied with written information about the outpatient psycho-oncology 
service (on the reverse side of the DT; see Appendix B) prior to their first outpatient 
oncological consultation. The participating oncologists were asked to inform all patients 
about the outpatient psycho-oncology service in the first consultation. In fact, 84% of all 
patients recalled this information, which was relatively simple and was provided both 
orally and in written form. These features seem essential if patients in highly stressful 
situations are to remember the information provided (Finset, 2015; Kessels, 2003; 
Langewitz et al., 2015). 
More than half of all patients reported a normative need for support (i.e., high 
distress values of DT³5). In our study, psychosocial distress levels were slightly higher 
than those reported in other studies (Carlson et al., 2010; Zabora et al., 2001), which might 
be explained by the time of data collection. Using the DT, we routinely screened all 
patients for psychosocial distress shortly before the first consultation with the oncologist, 
when patients receive information about their cancer and treatment options, evoking 
existential fear and stress. In most other studies, distress was assessed at home or at various 
times at the clinic but rarely prior to the first consultation (Admiraal et al., 2016; Faller, 
Weis, et al., 2016). 
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In our study, 25% of all patients expressed a need to access the psycho-oncology 
service (intention yes); 42% expressed no need (intention no); and 33% were ambivalent 
(intention maybe). Combining normative and expressed needs, 67% of highly distressed 
patients (DT³5) did not want to make immediate use of the psycho-oncology service (35% 
no; 32% maybe). At the same time, 45% of low distressed cancer patients (DT<5) were 
open to psycho-oncological support (15% yes; 30% maybe). These results align with many 
other studies reporting 42–75% of high distressed cancer patients with no need for support 
and 10–44% of low distressed patients with a need for support (see section 2.1.4). Our 
results highlight the difficulties encountered in referring patients experiencing a high level 
of distress to supportive care services.  
The novel aspect of our study was its qualitative approach, which enabled us to 
identify different patterns of emerging motives for declining psycho-oncological support. 
By identifying these patterns, we can improve referral of patients with high distress levels 
to supportive care services. In line with the findings of Clover and colleagues (Clover et 
al., 2015), we identified three main reasons for declining support: existing social support, 
subjective well-being, and self-determination/ self-management. Additionally, we found 
negative attitudes towards psychological support. Negative attitudes may reflect a 
biomedical understanding of illness and a tendency to avoid help-seeking behaviour that 
is common in mental health care settings (Clover et al., 2015). However, the needs of these 
patients might be better met by approaches that focus on reducing stigmatization and 
enhancing self-determination.  
In contrast, the needs of patients with maybe intention might be better addressed 
by taking an “if-then” approach to discussing service uptake. This group cited reasons 
both for psychological support (e.g. fears and uncertainties) and against it (e.g. existing 
social support; subjective well-being). These entailed a lot of if-then thinking (e.g. “if the 
treatment has side effects then I might use the service”), while remaining open to using 
the service at a later stage. Their distress levels were significantly raised as compared to 
the no intention group, but they were unable to decide between uptake and refusal, 
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confirming the tremendous uncertainty that patients experience during the first weeks 
following a cancer diagnosis.  
Patients with an ambivalent intention may have gone unrecognized in clinical 
practice to date because supportive care needs are captured (if at all) only once, using a 
dichotomous response format (yes/no) and are not routinely repeated if, for example, a 
patient’s health deteriorates, if social support diminishes, or if treatment causes side effects 
(Baker-Glenn et al., 2011). To capture all of a cancer patient’s need for supportive health 
care, a threefold assessment (yes/maybe/no) is recommended. Finding the right approach 
to meet the needs of each individual could optimise psycho-oncological health care 
delivery. 
Patients with a yes intention reported positive attitudes to psychological support, 
knowledge about what psychologists do and how they could help, and support-seeking 
concepts of coping. By implication, mental health literacy, knowledge, and patient 
empowerment seem important for patients’ verbalization of need and may increase service 
uptake (Faller et al., 2017; Faller, Koch, et al., 2016; Mehnert & Koch, 2008; Neumann et 
al., 2010; Salander, 2010; Steginga et al., 2008). On that basis, supportive cancer care 
should always include detailed information about access to and benefits of psycho-
oncological support.  
In total, 23% of all cancer patients used the outpatient psycho-oncology service 
over a period of four months. Among these, 65% of high distressed patients who expressed 
a yes intention actually used the service while 7% who expressed a no intention and 12% 
who expressed a maybe intention used the service. It is well known that some patients who 
want and are offered psycho-oncological support do not attend (Brebach et al., 2016) and 
that needs can change over time (Baker et al., 2013; McCormick & Conley, 1995). In their 
qualitative study, Baker and colleagues concluded that treatment stage influences patients’ 
readiness to address emotional needs (Baker et al., 2013). 
As in previous studies, we found that patient-related characteristics like younger 
age and higher education level predicted psycho-oncology service uptake (Faller et al., 
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2017; Faller, Weis, et al., 2016; Mehnert & Koch, 2008; Steginga et al., 2008; Zeissig, 
Singer, Koch, Blettner, & Arndt, 2014), as did higher distress levels (Curry, Cossich, 
Matthews, Beresford, & McLachlan, 2002; Faller et al., 2017; Steginga et al., 2008). In 
contrast to other studies, however, female gender was not associated with higher uptake 
(Clark et al., 2017; Ernst, Lehmann, Krauß, Köhler, & Schwarz, 2009). In general, further 
attempts should be made to understand the supportive care needs of older and less well-
educated patients.  
Interestingly, the strongest predictor of psycho-oncology service uptake was not 
level of distress or another patient-related characteristic. Rather, patients who reported an 
oncologist recommendation to attend the psycho-oncology service were six times more 
likely to use the service than those who did not report an oncologist recommendation. In 
other words, in a situation of huge uncertainty and threat, patients seem to trust 
oncologists’ expertise and judgement, confirming that trustful patient-clinician 
relationships are crucial in cancer care. Our study supports recent findings (Beesley et al., 
2016; Salmon & Young, 2017a, 2017b) that these trustful relationships depend on a 
patients’ perception of clinicians’ expertise and authority. Vulnerable patients are likely 
to form an emotional bond with a clinician to whom they attribute experience and the 
power to build a secure base when facing the threat of cancer (Salmon & Young, 2017b).  
At the same time, patients who were unsure whether an oncologist had 
recommended attending the psycho-oncology service were also four times more likely to 
access the service than patients who did not report an oncologist recommendation. These 
patients either did not remember the recommendation, did not remember the source of the 
information (e.g. oncologist/nurse/friend/spouse; first/second consultation), or were 
already positively disposed to psychological support and the answer was socially desired. 
We found that patients’ attitudes were strong indicators of their intention to use or refuse 
psycho-oncological support (along with coping, distress, and support). Patients’ attitudes 
to psycho-oncological support may influence both help-seeking and attendance; they may 
also affect the behaviour of oncologists, who may be more likely to initiate discussions 
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and provide a referral if they detect more explicit and frequent signs of psychosocial 
concern (Sheldon, Blonquist, Hilaire, Hong, & Berry, 2014). We also found that factors 
other than level of distress influenced oncologists’ decisions to give or withhold a 
recommendation, including existing social support, absence of need, negative attitude, and 
curative treatment intent. 
Patients in our study did not recall detailed information that oncologists claimed 
to have shared about the psycho-oncology service. First consultations are typically full of 
new and potentially stressful medical information about cancer treatment and goals, and 
there is evidence of lack of recall of relevant medical information (Gabrijel et al., 2008; 
Gattellari, Voigt, Butow, & Tattersall, 2002). Retention of information is limited in 
situations of intense emotion, cognitive complexity, and ambiguity (Epstein & Street, 
2007). Because survival is the principal goal, detailed information about the psycho-
oncology service may not meet the patient’s situational needs, and it may be better to share 
this information at a later appointment. 
From an oncologist’s perspective, the DT proved useful as a tool for initiating 
discussion about psychosocial distress and support options, creating an atmosphere of 
openness in which to address psychosocial issues. However, about half of the participating 
patients did not remember this conversation; these included older patients and those with 
higher initial distress levels, as well as patients who considered it less important to talk 
with their oncologists about psychosocial distress. Because we have no objective records 
of the consultations, it is difficult to conclude from the available data whether oncologists 
failed to communicate clearly enough or whether patients neglected or failed to recall the 
information. Mackenzie and colleagues found that most patients who preferred not to talk 
with the oncologist about their distress said that other issues were more important for them 
in an oncological consultation (Mackenzie et al., 2015). Additionally, oncologists and 
patients might have different views about what it means to talk about psychosocial 
distress. Nevertheless, it seems clear that oncologists who initiate the discussion of 
psychosocial distress may reduce the risk of unrecognized psychiatric comorbidities and 
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stigmatization by validating patients’ needs (Faller, Weis, et al., 2016; Jones et al., 2011; 
Mackenzie et al., 2015; Taylor et al., 2011; Wright et al., 2004). 
Given their influence, oncologists need to act sensitively and responsibly to help 
patients overcome any barriers to accessing psycho-oncological support. Our results 
highlight how distress screening tools create an opportunity for oncologists to initiate 
communication with their patients about distress and to recommend the psycho-oncology 
service to vulnerable patients. Oncologists should not become counsellors for patients, but 
they should be facilitators, creating an atmosphere in which cancer patients are encouraged 
to address their psychosocial concerns in the same way as their physical concerns, where 
psychological symptoms are assessed, health care needs are discussed, information is 
provided, and treatment options are considered.  
 
5.3 Future directions 
 
If oncologists are to understand patients’ needs and encourage highly distressed patients 
to accept potentially helpful psychosocial services, oncologists and patients must 
communicate effectively (Epstein & Street, 2007; Institut of Medicine, 2008). In this 
regard, distress screening programmes can benefit from new approaches 1) by training 
oncologists to communicate effectively about psychosocial distress and psychosocial 
health care needs, taking account of the communication context (e.g. expertise and 
authority preferred in situations of threat); 2) by promoting greater cognizance of the 
various individual and contextual factors that can influence information processing among 
patients (e.g. older age, high distress); and 3) by reiterating the issue of psychosocial 
distress and options for support at different phases of the oncological treatment, using 
different modes of communication such as combining oral and written information. 
The present findings support claims for new approaches to enhance patient-
oncologist communication and invite further investigation of how effective patient-
oncologist communication is achieved.  
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5.4 Strengths and limitations 
 
This project has several strengths and limitations. This was a single-centre study, 
conducted in a comprehensive cancer centre at a major Swiss university hospital. Single-
centre studies are common in the medical literature (Ellis et al., 2009; Gabrijel et al., 2008; 
Trevino, Fasciano, & Prigerson, 2013) and can provide valuable heuristic information. 
However, they may not be representative of institutional settings more generally; as they 
are likely to reflect national and cultural variations, international multicentre replication 
is required. 
In the present study, the consultant oncologist recruited patients. This strategy had 
several advantages. As oncologists are the first and closest contact for outpatients, being 
invited by a physician to participate in a psycho-oncological study may serve to reduce 
any associated stigma. There is no additional burden for cancer patients at a time of 
increased vulnerability while awaiting treatment, and the clinic is a naturalistic setting. 
However, there is also a risk of bias if oncologists informed only patients they considered 
to be interested or healthier. In fact, 13% of all eligible patients were not informed about 
the study; 28% of eligible patients did not want any further information about the study, 
and 12% refused to participate after being informed. Nevertheless, our sample was large 
and gender-balanced and included a broad range of cancer types. The sample was 
representative for our clinic and was comparable to other outpatient oncological settings 
using a stepped‐care model (Singer et al., 2017). Again, because of the originality of our 
recruitment strategy, the findings should be interpreted carefully, and replication will be 
necessary.  
We decided against audio- or video-recordings of consultations because of the 
large number of participants and because we did not want to disrupt the first consultation. 
For that reason, we have no objective record of the consultations. Instead, our findings are 
based on patients’ and oncologists’ subjective reports, which we consider central to their 
actual behaviour. Adopting a qualitative approach, we took notes during the interviews 
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and subsequently wrote reflective postscripts (Mey & Mruck, 2010). We countered 
possible interviewer bias by relying on a detailed interviewer manual and ensuring that 
interviewers were closely supervised. However, social desirability and recall biases must 
be acknowledged as potential sources of bias (Gabrijel et al., 2008; Van De Mortel, 2008).  
The present study offers a novel, in‐depth qualitative analysis of patients' 
supportive care needs as a crucial extension of previous research. To our knowledge, it is 
the first study to focus on the content of patient-oncologist communication during a 
standard distress screening procedure in routine oncology practice. It is also the first 
longitudinal study of a large sample of cancer patients in the early phase of cancer 
treatment to monitor psycho-oncology service uptake after documenting supportive care 
needs. 
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6   Conclusion 
To achieve evidence-based change in comprehensive cancer care, we examined patients’ 
distress, intention, and uptake of psycho-oncological support, and patient-oncologist 
communication during a standard distress screening procedure in a longitudinal, mixed-
methods prospective observational study.  
Severity of distress (normative need) was found to be quantitatively and 
qualitatively associated with patients intention (yes, maybe, no) to access psycho-
oncological support (expressed need). Other deciding factors included coping strategies, 
attitude to psychological support, and perceived social and professional support. Patients’ 
health care needs are relevant in comprehensive cancer care because more than half of 
highly distressed patients do not wish to make immediate use of the psycho-oncology 
service. However, we found that about half had no such intention while the other half was 
ambivalent. Finding the right approach to meet the needs of each patient group (e.g. 
enhancing self-determination vs. discussing “if-then” thinking) seems likely to optimise 
psycho-oncological health care delivery. 
Patients’ actual uptake of support was predicted by higher distress levels, younger 
age, and higher education level, as well as by oncologist recommendation to attend the 
service. Oncologists play a central role in comprehensive cancer care in terms of providing 
information, reducing stigmatization, and recommending attendance at the psycho-
oncology service. Repeated screening of distress and provision of detailed information 
about the psycho-oncology service during the cancer trajectory may support the goals of 
both patients and oncologists. For oncologists, the DT proved helpful in initiating a 
conversation about psychosocial distress and support services. However, older, less well-
educated, and high distressed patients often failed to recall much of the information that 
oncologists reported sharing. Towards improving comprehensive cancer care, we suggest 
that oncologists should address and discuss patients’ health care needs as a matter of 
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routine clinical practice, and distress screening programmes must consider new 
approaches to enhance patient-oncologist communication. 
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STUDY PROTOCOL Open Access
Understanding why cancer patients accept
or turn down psycho-oncological support: a
prospective observational study including
patients’ and clinicians’ perspectives on
communication about distress
Diana Zwahlen1,2* , Theresa Tondorf1,2, Sacha Rothschild2, Michael T. Koller3, Christoph Rochlitz2
and Alexander Kiss1
Abstract
Background: International standards prioritize introducing routine emotional distress screening in cancer care to
accurately identify patients who most need psycho-oncological treatment, and ensure that patients can access
appropriate supportive care. However, only a moderate proportion of distressed patients accepts referrals to or uses
psycho-oncological support services. Predictors and barriers to psycho-oncological support service utilization are
under-studied. We know little about how patients and oncologists perceive the discussions when oncologists
assess psychosocial distress with a screening instrument.
We aim to 1) assess the barriers and predictors of uptake of in-house psycho-oncological support along the distress
screening pathway in cancer patients treated at a University Oncology Outpatient Clinic and, 2) determine how patients
and clinicians perceive communication about psychosocial distress after screening with the Distress Thermometer.
Methods: This is a quantitative prospective observational study with qualitative aspects. We will examine medical and
demographic variables, cancer patient self-reports of various psychological measures, and aspects of the patient-clinician
communication as variables that potentially predict uptake of psycho-oncological support service. We will also assess the
patients’ reasons for accepting or refusing psycho-oncological support services. We assess at three points in time, based
on paper-and-pencil questionnaires and two patient interviews during the study period. We will monitor outcomes
(psycho-oncology service uptake) four months after study entry.
Discussion: The study will improve our understanding of characteristics of patients who accept or refuse psycho-
oncological support, and help us understand how patients’ and oncologists perceive communication about psychosocial
distress, and referral to a psycho-oncologist. We believe this is the first study to focus on factors that affect uptake or
rejection of psycho-oncological support services along the screening and referral pathway. The study 1) combines
standard assessment with qualitative data collection, 2) embraces patient and oncologist perspectives, and, 3) focuses on
patient-clinician communication about psychosocial issues raised by a standard screening instrument.
Our results may improve routine practices and eliminate barriers to adequate health care, and make it easier to recognize
patients with high distress levels who underuse the service.
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Background
Routine distress screening identifies patients who experts
believe most need psycho-oncological care. This screening
is intended to give patients access to supportive care
services. Distress screening also identifies comorbidities,
including depression and anxiety. The Distress Thermom-
eter (DT) is widely used and has been validated as a reli-
able and valid screening tool [1–5]. Distress screening is
now an international standard in comprehensive care of
cancer patients [6, 7] and, in many countries, a criterion
for cancer center accreditation [8, 9]. In principle, distress
screening should identify cancer patients in psychosocial
distress and direct them to appropriate treatment services
but, in practice, it is debatable whether they can solve the
challenges posed by this process [10, 11].
Studies that investigated distress screening, referral,
and acceptance of professional support service found
low correspondence between emotional distress and up-
take. Some studies found that patients who reported a
higher burden of emotional symptoms were more likely
to access services than those who reported a lower
burden of symptoms [12–16]. Referral rates and re-
source utilization still seem low, given documented high
levels of distress. Various studies report that distress
correlates moderately or not at all with the wish for
support or acceptance of a referral [17–19]. Distress
scores and expert perspectives do not appear to reflect
patients’ needs for psycho-oncological support. It would
thus be very useful to be able to offer recommendations
on managing discordance between patient preference
and screening results.
In addition to the clinical screening and referral
process, there are other potential predictors of psycho-
oncological support service uptake than emotional dis-
tress. We have some evidence that patient characteristics
are linked to psycho-oncological support uptake: being
younger [15, 18, 20], being female [18, 21, 22], and being
more highly educated [15, 21, 23, 24].
Gaining insight into the patient decision process for or
against support uptake is difficult. Although the patient-
clinician conversation is an important element in the
screening and referral process [25, 26], we do not know
how patients and physicians perceive communication
after distress, or how their perceptions influence the
referral process. Few studies investigate the subjective
reasons people accept or reject psycho-oncological
support services, and even fewer include qualitative
components. A recent review [27] found the primary
patient-reported reason for rejection is they perceive
no subjective need. The second reason was lack of
information about availability of psychological support
services. Other patient explanations include a prefer-
ence for self-managing symptoms, or the belief that
help would be ineffective.
Our overarching aim is to assess factors along the
distress screening and referral pathway, so we can map
the process by which patients take decisions for or
against uptake of psycho-oncological support service. In
our prospective observational study, we will consider
distress scores, medical and demographic variables,
patient self-reports of psychological and social support
measures, and aspects of the patient-clinician communi-
cation as potential predictors of uptake of psycho-
oncological services. We also want to assess patient and
physician perceptions of communication about psycho-
social issues, spurred by a standard screening instru-
ment. We will incorporate qualitative data and assess
the reasons patients give us for accepting or refusing
psycho-oncological support.
Our two principal research questions are: (1) Which
factors along the screening pathway determine uptake of
psycho-oncological support in ambulatory cancer pa-
tients; and, (2) When the DT stimulates conversations
between patients and clinicians about psychosocial
distress, how do they perceive those conversations?
Methods
Study design
This is a prospective, observational, quantitative single-
center study in the Oncology Outpatient Clinic of the
University Hospital Basel (Switzerland) medical center.
Study participants
Cancer patients are consecutively recruited from the
Oncology Outpatient Clinic, which receives approxi-
mately 600 new cancer patients per year. Patients are eli-
gible to participate if they meet the following inclusion
criteria: older than 18 years; diagnosed with any kind of
solid tumor or hematologic malignancy; first consult-
ation at the Oncology Outpatient Clinic; and, at least
one more scheduled appointment. We exclude patients
with insufficient command of the German language, and
patients too physically weak or cognitively incapacitated
to participate (evaluated by attending oncologists).
Participating clinicians are oncologists and residents
from the Medical Oncology Department.
Standard screening and referral procedure
Routine distress screening and referral guidelines were im-
plemented to conform to international guidelines [6] and
are standard procedure in the Oncology Outpatient Clinic
since 2012. Independent of study participation, patients
are given a distress screening form (Distress Thermom-
eter, DT) [6, 28] in the waiting area on the first visit at the
Oncology Outpatient Clinic, shortly before their consult-
ation. A nurse asks patients to fill in the questionnaire; pa-
tients then hand it to the attending oncologist. The back
side of the questionnaire contains information about
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available professional psycho-oncological support services
at the Oncology Outpatient Clinic. The oncologist
discusses the score with the patient during the first
consultation, if possible. Oncologists are advised to
recommend psycho-oncological support to patients with
clinically relevant level of distress, indicated by a score of
5 or higher on the DT. Mehnert et al. [28] guided by the
patient’s DT score and their own estimation of the clinic-
ally relevant level of the patient’s distress, the oncologist
recommends the patient to use psycho-oncological sup-
port services and discusses a referral. The patient’s wish
guides the referral.
Psycho-oncological support service at the Oncology
Outpatient Clinic
The psycho-oncological team at the Oncology Out-
patient Clinic is thoroughly integrated into the medical
oncology team; it is situated on the ward and attends
daily team meetings.
Oncologists’ training on distress screening and
communication
Oncologists were instructed about psycho-oncological
procedures in a one-hour communication training that
covered 1) how to discuss distress scores with patients,
and, 2) how to refer patients to the psycho-oncological
support service. An expert in the field of medical com-
munication and co-investigator of the study conducted
the training (A.K.).
Study procedure
Eligible patients are informed about the study by attend-
ing oncologists at their first consultation. All patients
willing to participate are approached by the study coord-
inator after the first or second consultation on the ward,
or contacted by telephone. Participants are then fully
informed about the study in a separate room or by tele-
phone and receive an informed consent form, a baseline
questionnaire, and a return envelope (T0). After they
provide written informed consent, participants are con-
tacted for a baseline interview within four weeks after
they are recruited (T1). Patient preference determines if
the interview will be by telephone or face-to-face at the
outpatient clinic. Four months later, participants receive
a follow-up questionnaire by mail with a return enve-
lope, and are contacted for a follow-up interview (T2).
Oncologists complete a structured paper-and-pencil
questionnaire after every first consultation with a new,
eligible patient (T0). Figure 1 provides an overview of
study procedure and study measures.
Summary of study visits:
– T0 (participant screening and oncologist assessment)
takes place when patients fill out the DT form at
their first consultation at the oncology outpatient
clinic. Patients receive the distress screening form
before the first consultation, and oncologists are
instructed to fill out a questionnaire afterwards.
– T1 (participant baseline assessment) is the baseline
assessment, a few days to four weeks after study
recruitment. This assessment includes the baseline
interview (telephone or face-to-face) and a
paper-and-pencil questionnaire (filled out at home).
– T2 (participant follow-up assessment and outcome
monitoring) takes place four months later by
follow-up interview (telephone or face-to-face) and a
paper-and-pencil questionnaire (filled out at home).
Outcome is monitored at T2.
Interview procedure and interviewer training
Interviews will be semi-structured and conversational. In-
terviewers will use prompts and reflections to encourage
patients to talk, and will ask open and closed questions to
elicit detail where necessary. Interviewers take notes on
patients’ answers to open-ended questions. We will use
content analysis to analyze patient answers (see section,
Analysis of qualitative data). To guarantee the quality of
the data collection process, we developed an interviewer’s
manual that ensures interviews will be of equally high
quality, regardless of interviewer. Interviewers will be
trained and supervised by an experienced clinical psycho-
oncologist (D.Z.).
Ethics and data safety
This study will be conducted in accord with Declaration
of Helsinki and Good Clinical Practice guidelines. The
local Ethics Committee in Basel, Switzerland (EKNZ)
approved the study (reference number EK 220/13). The
EKNZ is eligible to approve studies in the University
Hospital of Basel. Collected data will be de-identified
and stored in a study-specific electronic database system,
in a separate locker. A patient-specific identification
number (Patient ID) is used to encode patient data.
Patient identification data and patient study data will be
stored separately. The translation key that links patient
identification data to patient study data will be electron-
ically and physically separate from the study database
system.
Sociodemographic data, clinical data, and oncologists’
personal data
Sociodemographic data (age, gender, relationship status,
living status, children, education, profession, employment
status, monthly household income) is collected during the
baseline interview (T1). Clinical data (cancer type, tumor
staging, stage of disease, weeks since diagnosis, treatment
intention, current and past treatments, past cancer diag-
noses, comorbidities, ECOG scale) is retrieved from the
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hospital’s electronic database and from patients’ medical
records by an oncologist and co-author of the study (S.R.)
at baseline (T1) and follow-up (T2). Oncologists’ personal
data (age, gender, professional experience) is gathered by a
single e-mail questionnaire.
Primary outcome measure
The primary outcome is each participant’s attendance (yes/
no) of the in-house psycho-oncological support service (at
least one appointment) during the study period. Outcome
data is retrieved from patients’ medical records and is
ascertained by individual contact with the patient at T2.
Secondary outcome measures
Secondary outcomes include: 1) agreement of and
disparities between patient and clinician perceptions of
communication about psychosocial distress and referral
after DT screening (Table 1); 2) patients’ reasons for
(non-)uptake of psycho-oncological support; 3) social
support and coping measures; 4) psychosocial distress
measures; and, 5) attitudes towards psycho-oncological
support.
Psychosocial distress measures
Distress Thermometer (DT).
We use the German version of the NCCN Distress
Thermometer with Problem List (PL) as the screening
tool (T0) for self-reported psychosocial distress, and
to identify the causes of expressed distress [6, 28].
The DT is well-validated as a reliable screening tool
and has proven itself in clinical practice; it is short
and easy to administer [1–5]. The DT contains one
item: “Please circle the number [0-10] that best de-
scribes how much distress you have been experien-
cing in the past week including today.” Patients
answer on a vertical visual analogue scale from 0 (“no
distress”) to 10 (“extreme distress”). We use the cut-
off score of 5 or greater, which Mehnert and col-
leagues suggest indicates a clinically significant level
of distress [28]. The PL comprises five problem
categories (practical problems, family problems, emo-
tional problems, spiritual/religious concerns, physical
problems), and a total of 36 potential causes of
expressed distress, each of which can be answered
‘yes’ or ‘no’.
Fig. 1 Overview of study procedure and study measures. Legend: DT: Distress Thermometer; HADS: Hospital Anxiety and Depression Scale; ESSI:
ENRICHD social support inventory; FACT-G7: Health-related quality of life; FoP-Q-SF: Fear of Progression Questionnaire
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Hospital Anxiety and Depression Scale (HADS)
The HADS is a 14-item self-administered questionnaire
widely used to detect anxiety and depression in physic-
ally ill patients, including cancer patients, and is vali-
dated for the German language [29]. The questionnaire
has two subscales (anxiety and depression) of seven
items each, and a total score for each subscale (values
from 0 to 21). Subscale scores between 0 and 7 indi-
cate normal anxiety and depression levels, scores
between 8 and 10 indicate borderline levels of anxiety
and depression, and scores between 11 and 21 indi-
cate clinical levels of anxiety or depression [30]. The
questionnaire is administered to participants at
baseline (T1) and follow-up (T2).
Fear of Progression Questionnaire (FoP-Q-SF)
The Fear of Progression Questionnaire short form (FoP-
Q-SF) is a 12-item self-report questionnaire used to
assess the fear of disease progression in physically ill
patients [31]. The German version of the FoP-Q-SF is
validated in cancer patients and is a reliable instrument,
and a total sum score (higher values indicate higher
levels of fear of progression) without a standardized
cutoff score for clinically relevant level of fear of
progression [32, 33]. The questionnaire is administered
to participants at baseline (T1) and follow-up (T2).
Health-related quality of life (FACT-G7)
The German 7-item version of the Functional Assess-
ment of Cancer Therapy - General (FACT-G) was
chosen to assess health-related quality of life in cancer
patients at baseline (T1) and follow-up (T2) [34]. The
scale comprises three physical well-being items (fatigue,
pain, nausea), one emotional well-being item (worry
about condition worsening), and three functional well-
being items (enjoyment of life, satisfaction with life,
sleep). The recall period is the past seven days, and an-
swers range from 0 (“not at all”) to 4 (“very much”) on a
5-point Likert-type scale. The total is the sum of all
scores; higher values reflect higher health-related quality
of life.
Table 1 Patients’ and oncologists’ perception of the first consultation
Variables Patients’ Baseline Interview Questions (T1) Oncologists’ Questionnaire Items (T0)
Talking about psychosocial distress Q: “Did the oncologist talk about your psychosocial
distress with you?”
Q: “Did you talk with the patient about his/her
psychosocial distress?”
A: Yes/ No/ Don’t remember A: Yes/ No
Importance of talking about psychosocial
distress
Q: “How important was it for you to talk about your
psychosocial distress with the oncologist?”
Q: “How important was it for the patient to talk
about his/her psychosocial distress?”
A: Scale from 0 “not important at all” to 10 “very
important”
A: scale from 0 “not important at all” to 10 “very
important”
Information about psycho-oncological
support
Q: “Did the oncologist inform you about the
psycho-oncological support service?”
Q: “Did you inform the patient about the
psycho-oncological support service?”
A: Yes/ No/ Don’t remember A: Yes/ No
Specification of psycho-oncological support Q: “Did the oncologist inform you about how the
psycho-oncologist can provide support?”
Q: “Did you inform the patient about how the
psycho-oncologist can provide support?”
A: Yes/ No/ Don’t remember A: Yes/ No
Recommendation of psycho-oncological
support
Q: “Did the oncologist recommend that you attend
the psycho-oncological support service?”
Q: “Did you recommend that the patient attends
the psycho-oncological support service?”
A: Yes/ No/ Don’t remember A: Yes/ No
Helpfulness of psycho-oncological support Q: “How helpful do you think psycho-oncological
support would be for yourself?”
Q: “How helpful do you think psycho-oncological
support would be for the patient?”
A: scale from 0 “not helpful at all” to 10 “very helpful A: scale from 0 “not helpful at all” to 10 “very
helpful
Perceived level of psychosocial distress° Q: “How much distress have you been experiencing
in the past week including today?”
Q: “How do you perceive the level of distress
of the patient?”
A: Scale from 0 “no distress” to 10 “extreme distress” A: scale from 0 “no distress” to 10 “extreme
distress”
Content of psychosocial distress° Q: “What are your greatest burdens?” Q: “What are the patient’s greatest burdens?”
A: open answer field A: open answer field
Trust in oncologist Q: “How comfortable do you feel talking to the
oncologist about personal issues?”
-
A: scale from 0 “not at all” to 10 “very much” -
Q Question/Item, A Answer format. °Questions repeated in patients’ follow-up interview (T2)
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Social support and coping measures
ENRICHD social support inventory (ESSI).
The ESSI is a reliable and valid 5-item self-report
measurement of perceived social support in physically ill
patients [35]. We use the German version of the ESSI,
which has good psychometric properties [36]. Answers
are given on a 5-point Likertscale from 1 (“never”) to 5
(“always”). Scores are summed (range 5–25) and higher
scores indicate higher levels of perceived social support.
Scores are dichotomized into high and low social
support. Low social support is defined as a score of 18
or less, with at least two items that score 3 or less [36].
The questionnaire is administered to participants at
baseline (T1) and follow-up (T2).
Other support services
Participants are asked if they attend psychosocial sup-
port services outside of the University Hospital Basel
(assessed at T1 and T2; including psychiatric, psycho-
logical, or psycho-oncological support, social service,
pastoral care, alternative medicine, complementary
medicine).
Coping measures
Several questions elicit details on a patient’s subjective
perception of how they are coping with cancer, includ-
ing: perceived threat (“How threatening is the illness to
you right now?”, scale from 0 “not threatening at all” to
10 “very threatening”); self-evaluation of coping (“How
well are you dealing with your illness at the moment?”,
scale from 0 “not good at all” to 10 “very good”);
resources for coping (open question: “Who or what has
helped you so far in dealing with your illness?”); and,
need to talk with someone (“Do you perceive a need to
talk with someone about your illness?”, from which
patients can select either with friends/family, with a
professional person, with both, or with no one).
Patient-physician communication
Table 1 gives an overview of variables that shape the
perception of the first consultation, from the patient and
oncologist perspectives.
Patients’ perception of the conversation with the
oncologist
Several questions in the baseline interview address the
patient’s perception of the conversation about psycho-
social issues and psycho-oncological support with the
oncologist during their first consultation (T1; details see
Table 1).
Oncologists’ perception of the conversation with the
patient and evaluation of distress screening
Oncologists are asked to evaluate, on a paper-and-pencil
questionnaire, their view of the conversation about psy-
chosocial issues and psycho-oncological support options
based on the DT in the first consultation (T0; details see
Table 1). Reasons for not talking about psychosocial dis-
tress with the patient and reasons for not recommending
psycho-oncological support are assessed in open answer
fields. Oncologists are also asked to assess the usefulness
of the DT (“How helpful was the DT in the consultation
with the patient?”), rated on a scale from 0 (“not helpful
at all”) to 10 (“very helpful”). If the oncologist found the
DT helpful, they are asked to specify why, with a choice
of six pre-formulated answers (multiple responses
possible):
1. “The DT was helpful to assess the patient's distress.”
2. “The DT was helpful to assess the patient’s
problems.”
3. “The DT was helpful to initiate the conversation
about psychosocial distress.”
4. “The DT was helpful to structure the conversation
about psychosocial distress.”
5. “The DT was helpful for referral to psycho-oncological
support service.”
6. “The DT was helpful for referral to social care or
pastoral care.”
Open ended questions to assess attitude and reasons for
or against uptake
Patients’ attitudes towards psycho-oncological support.
At baseline, attitude towards psycho-oncological
support for cancer patients in general is assessed (T1)
on a scale from 0 (“not meaningful at all”) to 10 (“very
meaningful”). Patients are also asked what expectations
and fears they have about psycho-oncological support
(open-ended question), if they have ever used psycho-
logical support services (yes, no), and how they evaluate
their experience, from 0 (“not helpful at all”) to 10 (“very
helpful”).
Participants’ intention and reasons for (non-) uptake of
psycho-oncological support
At baseline (T1), we assess participants’ prospective
intention to use psycho-oncological support services
(“Do you intend to uptake the in-house psycho-
oncological support service in the next months?” answer
options: yes, maybe, no), and their reasons (in an open-
ended question: “What are the reasons why you do [not/
may] intend to use the in-house psycho-oncological sup-
port service?”). At follow-up (T2), we use an open-ended
question to assess patients’ retrospective reasons for
using or refusing psycho-oncological support services in
Zwahlen et al. BMC Cancer  (2017) 17:385 Page 6 of 10
  92 
 
 
the last four months (“What are the reasons why you
did/ did not use the in-house psycho-oncological sup-
port service in the last months?”). We analyze the con-
tent of responses to open-ended questions (see below).
Statistical methods
Sample size estimation
We estimate recruitment period will last 26 months based,
since about 600 new patients attend the oncology out-
patient clinics per year. We plan to enroll 700 patients
during this period, expect an attendance rate of 20% for
the psycho-oncological support service, and a dropout
rate of no more than 25%. We estimate that 140 of our
study patients will have an outcome, which gives us the
power to spend around 9 to 14 degrees of freedom (10–15
events per degree of freedom) in the final regression
model and to avoid overfitting the model.
Statistical analysis
This project allows us to address questions related to the
uptake or non-uptake of psycho-oncological services. We
are primarily interested in individual patient factors, and
physician-related factors that explain and predict uptake of
psycho-oncological services. Statistical methods are thus
specified separately for each research question. To de-
scribe the population characteristics of enrolled patients,
we will display the frequency distributions for categorical
data and means or medians for continuous data.
The primary outcome and aim of the project are pa-
tient and physician factors of psycho-oncological service
uptake. The primary outcome of service uptake or non-
uptake is defined and ascertained as a binary variable,
which we will analyze with logistic regression analysis.
To develop explanatory models for the primary out-
come, we will first consider expert knowledge to define
candidate predictors and potential interactions. We will
also explore alternative candidate selection techniques as
described by Harrell [37] and Steyerberg [38], and com-
pare the properties of the different models. For continu-
ous predictors (patient age, DT measurement, etc.), we
will check the linearity assumption with restricted cubic
spline transformations [37, 38]. To deal with potential
missing covariate values, we will use multiple imputation
and compare the complete case analyses.
Analyses that focus on oncologist perceptions of
patients’ distress and their need for psycho-oncological
service referral will cluster within physicians. In these
situations, we may use robust estimation or random-
effects modeling to account for clustering. We may use
intra-class correlation to assess variance components be-
tween physicians for numeric data and contingency table
analyses, or hierarchical modelling to assess paired
patient-physician consultation data with binary response
variables.
If there was a follow up assessment, the data of that
assessment will be entered for analyses. We will use
descriptive methods to summarize the frequency (cat-
egorical variables) or the distribution of continuous
(means [SD] or median [IQR]) baseline variables and the
frequency distribution of the dependent variable. We
will also run and report comprehensive analyses of miss-
ing data and drop out. We will use logistic regression
analysis to test the impact of the predictor variables (see,
“objectives and research question”) on the outcome use
or non-use of psycho-oncologic support.
We will assess univariate associations in logistic re-
gression analysis. We will select relevant predictor
variables for multivariable models using univariate pre-
selection, based on a liberal p-value of p < 0.2 [37, 38].
Other than adjusting for age and gender, we will retain
significant predictors in the multivariable model based
on a type-1 error rate of 5%. For continuous predictors,
we will also study non-linear associations using
restricted cubic spline transformations with 3–5 knots
[37, 38]. Independent variables that arise from patient-
physician communication will be “nested within physi-
cians”. We will thus consider using multilevel modeling
to account for within physician correlation. If within
patient correlation (intra-class correlation) is low (e.g.
< 0.05), this will indicate that the variance components
between physicians are low. In this situation, regression
models for the total patient sample will reveal unbiased
SEs. To check agreement between patient and physician
perceptions, depending on the nature of the measure-
ment, we will use contingency table analyses or compute
the intra-class correlation.
Analysis of qualitative data
Interviewers will be trained to note key messages of
patients’ answers to open-ended questions. Patients’
answers will be recorded in first person. We will use
Content Analysis to analyze responses to open-ended
questions [39], in MAXQDA 12 (VERBI Software,
Germany), a qualitative data analysis software program.
A team of trained researchers will discuss the responses
to guarantee high quality content analysis. Cohen’s
kappa statistics (κ) will be used to assess inter-rater
reliability between independent raters.
Discussion
Many patients with high distress levels do not want
psycho-oncological support [40]. This prospective obser-
vational study will help us identify predictors and
barriers to psycho-oncological support service uptake
along the distress screening pathway. We will learn what
patients and oncologists think of their communication
about psychosocial distress, based on results from a
distress screening tool.
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We believe this is the first study to consider factors
along the distress screening and referral pathway to map
the decision process of patients. We 1) combine stand-
ard assessment with qualitative data collection, 2)
embrace patient and oncologist perspectives, and, 3)
focus on communication-related aspects of the distress
screening procedure.
Clinical practice and research show that severity of
distress is not the only deciding factor in whether a pa-
tient accepts a referral to psychosocial services. The
presence of clinically relevant levels of psychological dis-
tress does not necessarily translate into a patient’s desire
for referral for treatment, but patients with negative
screens may ask for psycho-oncological services, e.g.
[17–19].
Patient characteristics linked to support service uptake
Research has linked older age [15, 18, 20] and lower edu-
cation [15, 21, 23, 24] to less service use, even when older
and less-educated patients have higher levels of distress,
pain, and fatigue. Some studies report that women [18, 21,
22] are more likely to be referred to psycho-social services.
But Waller [15] found that very fatigued women were less
likely to access services than very fatigued men. Other
contextual factors, including treatment modalities, were
associated in different ways with patients’ desire for psy-
chological support. Evidence on additional patient charac-
teristics and clinical aspects associated with acceptance of
psycho-oncological support other than distress is rare, and
participants and study designs were heterogeneous.
Patient-physician conversation based on results from a
distress screening tool
Communication about psychosocial issues is delicate.
There is evidence that clinicians do not systematically
inquire into the emotional problems of patients, and
many clinicians prefer patients to bring up a problem.
On the other hand, patients are reluctant to disclose
problems [41]. They may have trouble sharing emotional
difficulties, and some do not want to address distress
and all [42]. In distress screening, we do not know how
patients perceive the following conversation about
psychosocial issues.
Effective patient-clinician communication encourages
patients to openly express psychosocial needs, and to re-
ceive and understand information. The perspectives of
patients and clinicians must be aligned in a patient-
centered communication process designed to overcome
barriers to effective communication [43]. Bultz, et al.,
[26] emphasize that interacting with the patient is the
essential element of an effective screening procedure.
Despite this, no screening tool offers detailed recom-
mendations to guide physician interaction and commu-
nication with the patient. Discussing a patient’s distress
score on a screening tool opens an opportunity for phys-
ician and patient to effectively communicate about
psychosocial issues and psychosocial health needs.
Mitchell [44] reported that a screening tool like the
Distress Thermometer positively influenced communica-
tions about psycho-social issues and distress; clinicians
believed the screening program improved communica-
tion in more than 50% of assessments. Ours will be the
first study to give attention to patient-physician commu-
nication stimulated by a distress screening instrument,
and to ask how both patient and physician perceive the
process.
Patient reasons for or against support service uptake
In their review, Dilworth and colleagues [27] describe
the primary patient-reported reason for refusing support
services as, “no subjective need for psychosocial ser-
vices” (38.7% of pts). This broad reason could include,
e.g., a preference for self-managing symptoms, not feel-
ing distressed enough, the belief that help would be inef-
fective, and receiving sufficient support from family and
friends. The second most important barrier in the Dil-
worth review is context-related. Patients reported they
lacked information about the availability of psychological
support services (19.0% of pts).
Studies that investigate the reasons patients choose or re-
fuse psycho-oncological assistance rarely include qualita-
tive aspects. A recent study [40] reported that, even in
patients with high distress scores, a patient’s preference for
self-help and their belief that their distress is not severe
enough are common barriers. Mosher [45] had similar re-
sults, and also identified inadequate knowledge of services
as a patient-reported barrier. A qualitative study found that
both a patient’s desire for normalcy and their lack of infor-
mation about the potential benefits of psycho-oncological
treatment could lead patients to refuse psycho-oncological
support. The subjective norms and information deficits of
physicians also influenced the choice of patients to use
psycho-oncological support services [46].
Limitations
The mono-center setting is both an asset and a liability.
Conducted at one University Oncology Outpatient Clinic,
our observational study is embedded in a clinic culture
that takes a well-accepted interdisciplinary approach, in-
cluding systematic integration of the psycho-oncological
support service team. A study coordinator on the oncol-
ogy team can closely monitor procedure. The single set-
ting, however, may limit generalizability of our results.
Funding limits permits us only four months of follow-
up, so we will not be able to draw long-term conclusions
about uptake of psycho-oncological support at later
stages of treatment, or in transition phases of illness.
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The interviews we conduct may affect participant
uptake of support services. This non-interventional ob-
servational study will interview participants twice, and
ask them why they would or would not want to use
psycho-oncological support services. Being asked these
questions may motivate and interest participants in
using support services. We cannot exclude this effect
but, in the follow-up interview, we will ask the partici-
pant if this was one reason they used services.
Conclusions
To raise the quality of psychosocial cancer care, we need
to move beyond simple diagnosis and consider the screen-
ing process as whole, from a health care delivery perspec-
tive. Better understanding the perspectives and potential
difficulties in the communication process will help us craft
recommendations to improve communication guidelines
for distress screening. If we better understand determi-
nants and barriers along the distress screening pathway,
we may be able to increase access for underserved groups
of distressed cancer patients. We hope to identify routine
practices that can lower or eliminate barriers to adequate
health care, and better meet patient needs, so we can
deploy resources in psychosocial cancer care more
efficiently and manage patients better.
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Appendix B: Distress Thermometer 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sprechstunden nach Vereinbarung 
 
Stv. Chefarzt Prof. Dr. A. Zippelius Leitende Ärztin Prof. Dr. V. Hess, Leitender Arzt PD Dr. F. Stenner 
Oberärztinnen Dr. K. Conen, Dr. F. Krasniqi, Oberärzte Dr. S. Rothschild, Dr. M. Vetter, Dr. A. Wicki  
Leitung Pflegedienst A. Hertig, MSc 
Weitere Informationen unter: 
http://www.unispital-basel.ch/das-universitaetsspital/bereiche/medizin/kliniken-institute-abteilungen/onkologie/  
 
 
 
 
 
 
Ihr ganzheitliches Wohlbefinden interessiert uns! 
 
 
Sehr geehrte Damen und Herren 
 
Körperliches und seelisches Wohlbefinden sind untrennbar miteinander 
verbunden. Die Diagnose einer Krankheit kann seelische Veränderungen bewirken 
– für direkt Betroffene und für ihre Angehörigen. Aus diesem Grund gehört die 
psychologische Fachperson zu unserem Behandlungsteam. Unsere 
Psychoonkologinnen, Frau Franziska Durstewitz, Frau Astrid Grossert und Frau 
Diana Zwahlen, betreuen und begleiten Sie und Ihre Angehörigen zusammen mit 
Ärzten und Pflegenden, wenn Sie dies wünschen. Diese Leistung wird von der 
Krankenkasse übernommen. 
 
Für eine erste Einschätzung Ihrer momentanen Belastungssituation, möchten wir 
Sie bitten, auf der Rückseite dieses Blattes den so genannten 
„Belastungsthermometer“ auszufüllen.  
 
Bitte geben Sie den Fragebogen anschliessend Ihrem betreuenden Arzt oder Ihrer 
Ärztin bei der Konsultation ab. Er oder sie wird Ihre Angaben mit Ihnen 
besprechen.  
 
 
Ihr Team der Onkologie Basel 
 
 
Medizin 
Onkologie 
Chefarzt Prof. Christoph Rochlitz 
 
Universitätsspital Basel 
Petersgraben 4 
CH-4031 Basel 
Telefon +41 61 265 50 75 
Telefax +41 61 265 53 16 
Tel. Sekretariat +41 61 265 50 74/59 
Tel. Pflegedienst +41 61 265 50 03 
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JA NEIN  JA NEIN  
  Praktische Probleme   Körperliche Probleme 
⃝ ⃝ Wohnsituation ⃝ ⃝ Schmerzen 
⃝ ⃝ Versicherung ⃝ ⃝ Übelkeit 
⃝ ⃝ Arbeit/Schule ⃝ ⃝ Erschöpfung 
⃝ ⃝ Beförderung (Transport) ⃝ ⃝ Schlaf 
⃝ ⃝ Kinderbetreuung ⃝ ⃝ Bewegung/ Mobilität 
   ⃝ ⃝ Waschen/ Ankleiden 
  Familiäre Probleme ⃝ ⃝ Äusseres Erscheinungsbild 
⃝ ⃝ Im Umgang mit dem Partner ⃝ ⃝ Atmung 
⃝ ⃝ Im Umgang mit den Kindern ⃝ ⃝ Entzündungen im Mundbereich 
   ⃝ ⃝ Essen/ Ernährung 
  Emotionale Probleme ⃝ ⃝ Verdauungsstörungen 
⃝ ⃝ Sorgen ⃝ ⃝ Verstopfung 
⃝ ⃝ Ängste ⃝ ⃝ Durchfall 
⃝ ⃝ Traurigkeit ⃝ ⃝ Veränderungen beim Wasser lassen 
⃝ ⃝ Depression ⃝ ⃝ Fieber 
⃝ ⃝ Nervosität ⃝ ⃝ Trockene/ juckende Haut 
⃝ ⃝ Verlust des Interesses an  
alltäglichen Aktivitäten 
⃝ ⃝ Trockene/verstopfte Nase 
  ⃝ ⃝ Kribbeln in Händen/ Füssen 
   ⃝ ⃝ Angeschwollen/ aufgedunsen fühlen 
  Spirituelle/religiöse Belange ⃝ ⃝ Gedächtnis/ Konzentration 
⃝ ⃝ In Bezug auf Gott ⃝ ⃝ Sexuelle Probleme 
⃝ ⃝ Verlust des Glaubens    
 
Sonstige Probleme: 
 
 
 
Etikette        Datum:    Visum Arzt: 
 
 
 
 
ERSTENS: Bitte kreisen Sie am Thermometer rechts die 
Zahl ein (0-10), die am besten beschreibt, wie belastet Sie 
sich in der letzten Woche einschliesslich heute gefühlt 
haben.  
ZWEITENS: Bitte geben Sie an, ob Sie in einem der nachfolgenden Bereiche in der letzten Woche einschliesslich 
heute Probleme hatten. Kreuzen Sie für jeden Bereich JA oder NEIN an. 
Procedere (Arzt): 
Verlauf (PsyOnk): 
